| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 3.40e-09 | 4 | 154 | 4 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 3.40e-09 | 4 | 154 | 4 | GO:0047685 | |
| GeneOntologyMolecularFunction | protein kinase activity | EPHB2 SMG1 CDC42BPG VRK3 ATR GRK4 NRG2 PKMYT1 SCYL2 HIPK3 PHKA2 BMPR1B MAP4K5 MYO3B SYK TNK2 LYN MAP2K1 MAP2K2 FYN EIF2AK3 | 7.47e-09 | 600 | 154 | 21 | GO:0004672 |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 1.69e-08 | 5 | 154 | 4 | GO:0047894 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 1.17e-07 | 7 | 154 | 4 | GO:0050294 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB2 SMG1 CDC42BPG VRK3 ATR GRK4 NRG2 PKMYT1 SCYL2 HIPK3 PHKA2 BMPR1B MAP4K5 MYO3B SYK TNK2 LYN MAP2K1 MAP2K2 FYN EIF2AK3 | 1.29e-07 | 709 | 154 | 21 | GO:0016773 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | SMG1 CDC42BPG VRK3 ATR GRK4 PKMYT1 HIPK3 PHKA2 BMPR1B MAP4K5 MYO3B SYK TNK2 MAP2K1 MAP2K2 EIF2AK3 | 3.74e-07 | 446 | 154 | 16 | GO:0004674 |
| GeneOntologyMolecularFunction | sulfate binding | 4.16e-07 | 9 | 154 | 4 | GO:0043199 | |
| GeneOntologyMolecularFunction | kinase activity | EPHB2 SMG1 CDC42BPG VRK3 ATR GRK4 NRG2 PKMYT1 SCYL2 HIPK3 PHKA2 BMPR1B MAP4K5 MYO3B SYK TNK2 LYN MAP2K1 MAP2K2 FYN EIF2AK3 | 4.42e-07 | 764 | 154 | 21 | GO:0016301 |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 6.89e-07 | 10 | 154 | 4 | GO:0004062 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.90e-06 | 145 | 154 | 9 | GO:0004713 | |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 2.30e-06 | 13 | 154 | 4 | GO:0050656 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB2 SMG1 CDC42BPG VRK3 ATR GRK4 NRG2 PKMYT1 SCYL2 HIPK3 PHKA2 BMPR1B MAP4K5 MYO3B SYK TNK2 LYN MAP2K1 MAP2K2 FYN EIF2AK3 | 1.11e-05 | 938 | 154 | 21 | GO:0016772 |
| GeneOntologyMolecularFunction | sulfotransferase activity | 6.52e-05 | 55 | 154 | 5 | GO:0008146 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 8.37e-05 | 93 | 154 | 6 | GO:0097110 | |
| GeneOntologyMolecularFunction | nuclear export signal receptor activity | 9.40e-05 | 12 | 154 | 3 | GO:0005049 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | SMG1 CDC42BPG ATR PKMYT1 HIPK3 MAP4K5 MYO3B TNK2 MAP2K1 MAP2K2 EIF2AK3 | 1.22e-04 | 363 | 154 | 11 | GO:0106310 |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 2.68e-04 | 74 | 154 | 5 | GO:0016782 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 3.03e-04 | 42 | 154 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 3.96e-04 | 173 | 154 | 7 | GO:0070851 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 4.32e-04 | 46 | 154 | 4 | GO:0004715 | |
| GeneOntologyMolecularFunction | GTPase binding | DOCK1 DOCK3 RASA1 CDC42EP1 RANBP17 CSE1L XPO5 DIAPH2 MAP2K1 FGD6 | 4.95e-04 | 360 | 154 | 10 | GO:0051020 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | DIP2B STRBP ACTN1 ACTR3B ACTR3 ADD1 ADD2 ADD3 PTPN4 EEF2 MTUS1 MYO3B DIAPH2 DNM3 DMD LYN FYN EP300 AGTPBP1 | 8.21e-04 | 1099 | 154 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | type 5 metabotropic glutamate receptor binding | 8.69e-04 | 6 | 154 | 2 | GO:0031802 | |
| GeneOntologyMolecularFunction | small GTPase binding | 8.85e-04 | 321 | 154 | 9 | GO:0031267 | |
| GeneOntologyMolecularFunction | O-methyltransferase activity | 9.13e-04 | 25 | 154 | 3 | GO:0008171 | |
| GeneOntologyMolecularFunction | nucleocytoplasmic carrier activity | 1.89e-03 | 32 | 154 | 3 | GO:0140142 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 1.89e-03 | 32 | 154 | 3 | GO:0099186 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.94e-03 | 227 | 154 | 7 | GO:0051015 | |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 1.53e-08 | 5 | 155 | 4 | GO:0018960 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | EPHB2 SHANK1 SMG1 CCP110 ATR RASA1 VPS13C GBA2 ACTR3 SYDE1 ADD1 ADD2 ADD3 CDC42EP1 PKMYT1 VPS13D MYO3B SNX18 TENM1 WDR35 SMARCD2 PDCD10 MAP2K1 MAP2K2 ENDOG EP300 INO80B | 2.46e-06 | 1342 | 155 | 27 | GO:0033043 |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 2.50e-06 | 52 | 155 | 6 | GO:0008210 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | SHANK1 CDC42BPG RASA1 PCLO ACTN1 GBA2 ACTR3 SYDE1 ADD1 ADD2 ADD3 CDC42EP1 HMCN1 AMOT MYO3B DIAPH2 TENM1 PDCD10 FGD6 EP300 | 2.62e-06 | 803 | 155 | 20 | GO:0030036 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB2 SHANK1 DIP2B RASA1 GATA3 CDH23 MCF2 ACTN1 ACTR3 ADD1 CDC42EP1 BMPR1B MYO3B TET1 SEC24B PTPRQ DIAPH2 DNM3 DMD LYN MAP2K1 MAP2K2 FYN FGD6 EP300 | 3.05e-06 | 1194 | 155 | 25 | GO:0000902 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | EPHB2 SMG1 CDC42BPG DIP2B VRK3 ATR RASA1 HIPK3 PTPN4 MYO3B TENM1 SYK TNK2 DMD LYN PDCD10 MAP2K2 FYN EIF2AK3 EP300 CNTF AGTPBP1 | 4.01e-06 | 976 | 155 | 22 | GO:0018193 |
| GeneOntologyBiologicalProcess | regulation of cellular component size | DIP2B RASA1 PCLO GBA2 ACTR3 ADD1 ADD2 ADD3 CDC42EP1 MYO3B TENM1 KDM6A EP300 TP73 | 4.27e-06 | 426 | 155 | 14 | GO:0032535 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | EPHB2 CCP110 RAPGEF1 ACTR3 CDC42EP1 MYO3B TENM1 DNM3 DMD LYN MAP2K1 MAP2K2 FYN EP300 CNTF | 5.00e-06 | 494 | 155 | 15 | GO:0031346 |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 6.77e-06 | 17 | 155 | 4 | GO:0050427 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 6.77e-06 | 17 | 155 | 4 | GO:0034035 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 6.77e-06 | 17 | 155 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 8.65e-06 | 18 | 155 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | regulation of actin filament length | 9.05e-06 | 180 | 155 | 9 | GO:0030832 | |
| GeneOntologyBiologicalProcess | neuron development | EPHB2 SHANK1 DIP2B GATA3 CDH23 MCF2 RAPGEF1 GBA2 ACTR3 SCYL2 BMPR1B MYO3B TET1 SEC24B PTPRQ DIAPH2 TENM1 DNM3 DMD LYN MAP2K1 MAP2K2 FYN EP300 CNTF AGTPBP1 TP73 | 1.21e-05 | 1463 | 155 | 27 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB2 SHANK1 DIP2B GATA3 CDH23 MCF2 ACTR3 BMPR1B MYO3B TET1 SEC24B PTPRQ DIAPH2 DNM3 MAP2K1 MAP2K2 FYN EP300 | 1.37e-05 | 748 | 155 | 18 | GO:0048667 |
| GeneOntologyBiologicalProcess | actin filament polymerization | 1.40e-05 | 190 | 155 | 9 | GO:0030041 | |
| GeneOntologyBiologicalProcess | actin filament-based process | SHANK1 CDC42BPG RASA1 PCLO ACTN1 GBA2 ACTR3 SYDE1 ADD1 ADD2 ADD3 CDC42EP1 HMCN1 AMOT MYO3B DIAPH2 TENM1 PDCD10 FGD6 EP300 | 1.71e-05 | 912 | 155 | 20 | GO:0030029 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | DIP2B RASA1 PCLO GBA2 ACTR3 ADD1 ADD2 ADD3 CDC42EP1 MYO3B TENM1 WDR35 MAP2K1 KDM6A EP300 TP73 | 1.76e-05 | 618 | 155 | 16 | GO:0090066 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | EPHB2 DIP2B CCP110 GATA3 MCF2 RAPGEF1 ACTR3 CDC42EP1 MYO3B DIAPH2 TENM1 DNM3 DMD LYN MAP2K1 MAP2K2 FYN EP300 CNTF | 2.04e-05 | 846 | 155 | 19 | GO:0120035 |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | SMG1 VRK3 ATR HIPK3 MYO3B TENM1 SYK DMD PDCD10 MAP2K2 EIF2AK3 | 2.15e-05 | 307 | 155 | 11 | GO:0018105 |
| GeneOntologyBiologicalProcess | regulation of actin filament polymerization | 2.40e-05 | 156 | 155 | 8 | GO:0030833 | |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 2.43e-05 | 23 | 155 | 4 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 2.43e-05 | 23 | 155 | 4 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 2.43e-05 | 23 | 155 | 4 | GO:1990840 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 2.43e-05 | 23 | 155 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | EPHB2 DIP2B CCP110 GATA3 MCF2 RAPGEF1 ACTR3 CDC42EP1 MYO3B DIAPH2 TENM1 DNM3 DMD LYN MAP2K1 MAP2K2 FYN EP300 CNTF | 2.67e-05 | 863 | 155 | 19 | GO:0031344 |
| GeneOntologyBiologicalProcess | filopodium assembly | 2.69e-05 | 78 | 155 | 6 | GO:0046847 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | SMG1 VRK3 ATR HIPK3 MYO3B TENM1 SYK DMD PDCD10 MAP2K2 EIF2AK3 | 3.05e-05 | 319 | 155 | 11 | GO:0018209 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | EPHB2 CCP110 ABCA3 ATR RAPGEF1 ACTR3 ADD1 ADD3 CDC42EP1 VPS13D MYO3B SNX18 TENM1 SYK WDR35 DNM3 DMD LYN MAP2K1 MAP2K2 ENDOG FYN EP300 INO80B CNTF | 3.05e-05 | 1366 | 155 | 25 | GO:0051130 |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway involved in phagocytosis | 3.43e-05 | 25 | 155 | 4 | GO:0038096 | |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 3.43e-05 | 25 | 155 | 4 | GO:0002433 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | ATR VPS13C SMCHD1 EPC1 DIAPH2 SMARCD2 PDCD10 MAP2K1 MAP2K2 KDM6A EIF2AK3 EP300 INO80B CNTF TP73 | 4.67e-05 | 598 | 155 | 15 | GO:0080135 |
| GeneOntologyBiologicalProcess | sulfation | 4.71e-05 | 27 | 155 | 4 | GO:0051923 | |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | 4.76e-05 | 222 | 155 | 9 | GO:0008154 | |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 5.28e-05 | 54 | 155 | 5 | GO:0048013 | |
| GeneOntologyBiologicalProcess | regulation of actin polymerization or depolymerization | 5.91e-05 | 177 | 155 | 8 | GO:0008064 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | EPHB2 DIP2B GATA3 MCF2 RAPGEF1 ACTR3 DIAPH2 DNM3 DMD LYN MAP2K1 MAP2K2 FYN EP300 CNTF | 6.06e-05 | 612 | 155 | 15 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of filopodium assembly | 6.86e-05 | 57 | 155 | 5 | GO:0051489 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 1.13e-04 | 13 | 155 | 3 | GO:0009812 | |
| GeneOntologyBiologicalProcess | ERBB2-ERBB3 signaling pathway | 1.13e-04 | 13 | 155 | 3 | GO:0038133 | |
| GeneOntologyBiologicalProcess | Fc receptor mediated stimulatory signaling pathway | 1.34e-04 | 35 | 155 | 4 | GO:0002431 | |
| GeneOntologyBiologicalProcess | ERBB3 signaling pathway | 1.43e-04 | 14 | 155 | 3 | GO:0038129 | |
| GeneOntologyBiologicalProcess | positive regulation of filopodium assembly | 1.50e-04 | 36 | 155 | 4 | GO:0051491 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | SHANK1 RASA1 GBA2 ACTR3 ADD1 ADD2 ADD3 CDC42EP1 MYO3B TENM1 EP300 | 1.60e-04 | 384 | 155 | 11 | GO:0032956 |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway | 2.06e-04 | 39 | 155 | 4 | GO:0038094 | |
| GeneOntologyBiologicalProcess | response to glucocorticoid | 2.11e-04 | 160 | 155 | 7 | GO:0051384 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | EPHB2 SHANK1 DOCK1 CCP110 ABCA3 ATR RASA1 NRG2 RAPGEF1 GBA2 ACTR3 ADD1 ADD2 ADD3 CDC42EP1 MYO3B SNX18 TENM1 SYK DNM3 EP300 | 2.30e-04 | 1189 | 155 | 21 | GO:0044087 |
| GeneOntologyBiologicalProcess | catechol-containing compound metabolic process | 2.38e-04 | 74 | 155 | 5 | GO:0009712 | |
| GeneOntologyBiologicalProcess | catecholamine metabolic process | 2.38e-04 | 74 | 155 | 5 | GO:0006584 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | EPHB2 SDK2 GATA3 CDH23 MYO3B SEC24B PTPRQ CNTF AGTPBP1 IMPG2 | 2.77e-04 | 343 | 155 | 10 | GO:0090596 |
| GeneOntologyBiologicalProcess | regulation of Golgi organization | 3.13e-04 | 18 | 155 | 3 | GO:1903358 | |
| GeneOntologyBiologicalProcess | neuron projection retraction | 3.33e-04 | 4 | 155 | 2 | GO:0106028 | |
| GeneOntologyBiologicalProcess | regulation of Golgi inheritance | 3.33e-04 | 4 | 155 | 2 | GO:0090170 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex assembly | ABCA3 ATR RASA1 GBA2 ACTR3 ADD1 ADD2 ADD3 CDC42EP1 TENM1 SYK EP300 | 3.34e-04 | 489 | 155 | 12 | GO:0043254 |
| GeneOntologyBiologicalProcess | positive regulation of plasma membrane bounded cell projection assembly | 3.37e-04 | 123 | 155 | 6 | GO:0120034 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 3.37e-04 | 228 | 155 | 8 | GO:0046777 | |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 3.68e-04 | 231 | 155 | 8 | GO:0032271 | |
| GeneOntologyBiologicalProcess | positive regulation of cell size | 3.69e-04 | 19 | 155 | 3 | GO:0045793 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 3.90e-04 | 233 | 155 | 8 | GO:0031345 | |
| GeneOntologyBiologicalProcess | neuron projection organization | 4.00e-04 | 127 | 155 | 6 | GO:0106027 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection regeneration | 4.26e-04 | 47 | 155 | 4 | GO:0070570 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 4.26e-04 | 47 | 155 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | biogenic amine catabolic process | 4.32e-04 | 20 | 155 | 3 | GO:0042402 | |
| GeneOntologyBiologicalProcess | inner ear morphogenesis | 4.35e-04 | 129 | 155 | 6 | GO:0042472 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | 4.55e-04 | 300 | 155 | 9 | GO:0110053 | |
| GeneOntologyBiologicalProcess | actin filament organization | SHANK1 RASA1 ACTN1 GBA2 ACTR3 ADD1 ADD2 ADD3 CDC42EP1 DIAPH2 TENM1 PDCD10 | 4.78e-04 | 509 | 155 | 12 | GO:0007015 |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | SHANK1 RASA1 GBA2 ACTR3 ADD1 ADD2 ADD3 CDC42EP1 MYO3B TENM1 EP300 | 4.89e-04 | 438 | 155 | 11 | GO:0032970 |
| GeneOntologyBiologicalProcess | response to corticosteroid | 5.08e-04 | 185 | 155 | 7 | GO:0031960 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 5.53e-04 | 5 | 155 | 2 | GO:0045053 | |
| GeneOntologyBiologicalProcess | hydrogen peroxide-mediated programmed cell death | 5.77e-04 | 22 | 155 | 3 | GO:0010421 | |
| GeneOntologyBiologicalProcess | amine catabolic process | 5.77e-04 | 22 | 155 | 3 | GO:0009310 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | INTS1 APBA1 GATA3 LRP1B SYDE1 ADD1 BMI1 SF3B1 AMOT TET1 MAP2K1 ENDOG KDM6A | 5.80e-04 | 596 | 155 | 13 | GO:0001701 |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 6.04e-04 | 249 | 155 | 8 | GO:0010976 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | ABCA3 ATR RASA1 ADD3 SULT1A2 SULT1A4 SULT1A1 SULT1A3 DMD LYN EP300 TP73 | 6.28e-04 | 525 | 155 | 12 | GO:0009410 |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 6.33e-04 | 192 | 155 | 7 | GO:0050770 | |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB2 SHANK1 DIP2B GATA3 CDH23 MCF2 RAPGEF1 ACTR3 BMPR1B MYO3B TET1 SEC24B DIAPH2 DNM3 DMD LYN MAP2K1 MAP2K2 FYN EP300 CNTF | 6.41e-04 | 1285 | 155 | 21 | GO:0031175 |
| GeneOntologyBiologicalProcess | hematopoietic progenitor cell differentiation | 7.37e-04 | 197 | 155 | 7 | GO:0002244 | |
| GeneOntologyBiologicalProcess | programmed cell death in response to reactive oxygen species | 7.50e-04 | 24 | 155 | 3 | GO:0097468 | |
| GeneOntologyBiologicalProcess | negative regulation of ERK1 and ERK2 cascade | 7.56e-04 | 95 | 155 | 5 | GO:0070373 | |
| GeneOntologyBiologicalProcess | amine metabolic process | 8.96e-04 | 148 | 155 | 6 | GO:0009308 | |
| GeneOntologyBiologicalProcess | auditory receptor cell stereocilium organization | 9.53e-04 | 26 | 155 | 3 | GO:0060088 | |
| GeneOntologyBiologicalProcess | protein polymerization | 9.77e-04 | 334 | 155 | 9 | GO:0051258 | |
| GeneOntologyBiologicalProcess | ERBB2 signaling pathway | 1.07e-03 | 27 | 155 | 3 | GO:0038128 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB2 SHANK1 DIP2B GATA3 MCF2 ACTR3 BMPR1B TET1 DIAPH2 DNM3 DMD MAP2K1 MAP2K2 FYN EP300 | 1.07e-03 | 802 | 155 | 15 | GO:0048812 |
| GeneOntologyBiologicalProcess | ear morphogenesis | 1.10e-03 | 154 | 155 | 6 | GO:0042471 | |
| GeneOntologyBiologicalProcess | regulation of Ras protein signal transduction | 1.15e-03 | 61 | 155 | 4 | GO:0046578 | |
| GeneOntologyBiologicalProcess | positive regulation of Fc receptor mediated stimulatory signaling pathway | 1.15e-03 | 7 | 155 | 2 | GO:0060369 | |
| GeneOntologyBiologicalProcess | trachea formation | 1.15e-03 | 7 | 155 | 2 | GO:0060440 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrogen peroxide-mediated programmed cell death | 1.15e-03 | 7 | 155 | 2 | GO:1901300 | |
| GeneOntologyBiologicalProcess | chromatin organization | KDM3A ATR FBL SMCHD1 GATA3 BMI1 ZZZ3 SF3B1 MCM3AP TET1 EPC1 SMARCD2 MLLT6 KDM6A EP300 INO80B | 1.19e-03 | 896 | 155 | 16 | GO:0006325 |
| GeneOntologyBiologicalProcess | organelle inheritance | 1.19e-03 | 28 | 155 | 3 | GO:0048308 | |
| GeneOntologyBiologicalProcess | Golgi inheritance | 1.19e-03 | 28 | 155 | 3 | GO:0048313 | |
| GeneOntologyBiologicalProcess | negative regulation of axonogenesis | 1.22e-03 | 62 | 155 | 4 | GO:0050771 | |
| GeneOntologyBiologicalProcess | Fc receptor signaling pathway | 1.22e-03 | 62 | 155 | 4 | GO:0038093 | |
| GeneOntologyBiologicalProcess | RNA localization | 1.29e-03 | 217 | 155 | 7 | GO:0006403 | |
| GeneOntologyBiologicalProcess | barbed-end actin filament capping | 1.32e-03 | 29 | 155 | 3 | GO:0051016 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to hypoxia | 1.32e-03 | 29 | 155 | 3 | GO:1900037 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB2 SHANK1 DIP2B GATA3 MCF2 ACTR3 BMPR1B TET1 DIAPH2 DNM3 DMD MAP2K1 MAP2K2 FYN EP300 | 1.32e-03 | 819 | 155 | 15 | GO:0120039 |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | CCP110 ATR ACTR3 ADD3 CDC42EP1 VPS13D SNX18 TENM1 WDR35 ENDOG EP300 INO80B | 1.35e-03 | 574 | 155 | 12 | GO:0010638 |
| GeneOntologyBiologicalProcess | chromatin remodeling | KDM3A ATR FBL SMCHD1 GATA3 BMI1 SF3B1 MCM3AP TET1 EPC1 SMARCD2 KDM6A EP300 INO80B | 1.43e-03 | 741 | 155 | 14 | GO:0006338 |
| GeneOntologyCellularComponent | apical tubulobulbar complex | 5.46e-05 | 2 | 155 | 2 | GO:0061828 | |
| GeneOntologyCellularComponent | tubulobulbar complex | 1.63e-04 | 3 | 155 | 2 | GO:0036284 | |
| GeneOntologyCellularComponent | postsynapse | EPHB2 SHANK1 DOCK1 CACNA1S ATR PCLO APBA1 ACTN1 ACTR3 ADD1 ADD2 ADD3 CHRNG DNM3 TNK2 DMD LYN MAP2K1 FYN | 1.98e-04 | 1018 | 155 | 19 | GO:0098794 |
| MousePheno | enlarged gallbladder | 5.74e-06 | 28 | 132 | 5 | MP:0009342 | |
| MousePheno | abnormal gallbladder size | 1.14e-05 | 32 | 132 | 5 | MP:0020134 | |
| Domain | Kinase-like_dom | EPHB2 SMG1 CDC42BPG VRK3 ATR GRK4 PKMYT1 SCYL2 HIPK3 BMPR1B MAP4K5 MYO3B SYK DNM3 TNK2 DMD LYN MAP2K1 MAP2K2 FYN EIF2AK3 | 3.14e-09 | 542 | 152 | 21 | IPR011009 |
| Domain | ARM-type_fold | DOCK1 DOCK3 SMG1 ATR HGH1 INTS1 PSMD1 RSPRY1 SCYL2 RANBP17 CSE1L SF3B1 XPO5 DIAPH2 AGTPBP1 | 1.19e-07 | 339 | 152 | 15 | IPR016024 |
| Domain | Protein_kinase_ATP_BS | EPHB2 CDC42BPG GRK4 PKMYT1 HIPK3 BMPR1B MAP4K5 MYO3B SYK TNK2 LYN MAP2K1 MAP2K2 FYN EIF2AK3 | 4.96e-07 | 379 | 152 | 15 | IPR017441 |
| Domain | Prot_kinase_dom | EPHB2 CDC42BPG VRK3 GRK4 PKMYT1 SCYL2 HIPK3 BMPR1B MAP4K5 MYO3B SYK TNK2 LYN MAP2K1 MAP2K2 FYN EIF2AK3 | 5.12e-07 | 489 | 152 | 17 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | EPHB2 CDC42BPG VRK3 GRK4 PKMYT1 SCYL2 HIPK3 BMPR1B MAP4K5 MYO3B SYK TNK2 LYN MAP2K1 MAP2K2 FYN EIF2AK3 | 5.74e-07 | 493 | 152 | 17 | PS50011 |
| Domain | PROTEIN_KINASE_ATP | EPHB2 CDC42BPG VRK3 GRK4 PKMYT1 HIPK3 BMPR1B MAP4K5 MYO3B SYK TNK2 LYN MAP2K1 MAP2K2 FYN EIF2AK3 | 1.09e-06 | 459 | 152 | 16 | PS00107 |
| Domain | Aldolase_II | 2.10e-06 | 4 | 152 | 3 | SM01007 | |
| Domain | Aldolase_II/adducin_N | 2.10e-06 | 4 | 152 | 3 | IPR001303 | |
| Domain | Aldolase_II | 2.10e-06 | 4 | 152 | 3 | PF00596 | |
| Domain | - | 2.10e-06 | 4 | 152 | 3 | 3.40.225.10 | |
| Domain | ARM-like | SMG1 ATR HGH1 PSMD1 RSPRY1 SCYL2 RANBP17 CSE1L SF3B1 XPO5 AGTPBP1 | 1.35e-05 | 270 | 152 | 11 | IPR011989 |
| Domain | S_TKc | CDC42BPG VRK3 GRK4 PKMYT1 SCYL2 HIPK3 BMPR1B MAP4K5 MYO3B MAP2K1 MAP2K2 EIF2AK3 | 3.86e-05 | 359 | 152 | 12 | SM00220 |
| Domain | Pkinase | CDC42BPG VRK3 GRK4 PKMYT1 SCYL2 HIPK3 BMPR1B MAP4K5 MYO3B MAP2K1 MAP2K2 EIF2AK3 | 6.84e-05 | 381 | 152 | 12 | PF00069 |
| Domain | - | 8.69e-05 | 222 | 152 | 9 | 1.25.10.10 | |
| Domain | Ser/Thr_kinase_AS | CDC42BPG VRK3 GRK4 PKMYT1 HIPK3 BMPR1B MAP4K5 MYO3B MAP2K1 MAP2K2 EIF2AK3 | 1.67e-04 | 357 | 152 | 11 | IPR008271 |
| Domain | PROTEIN_KINASE_ST | CDC42BPG VRK3 GRK4 PKMYT1 HIPK3 BMPR1B MAP4K5 MYO3B MAP2K1 MAP2K2 EIF2AK3 | 1.89e-04 | 362 | 152 | 11 | PS00108 |
| Domain | Arp3_met | 1.96e-04 | 3 | 152 | 2 | IPR015623 | |
| Domain | VPS13 | 1.96e-04 | 3 | 152 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 1.96e-04 | 3 | 152 | 2 | PF16910 | |
| Domain | VPS13 | 1.96e-04 | 3 | 152 | 2 | PF16908 | |
| Domain | VPS13_N2 | 1.96e-04 | 3 | 152 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 1.96e-04 | 3 | 152 | 2 | IPR031642 | |
| Domain | Sulfotransfer_1 | 2.03e-04 | 36 | 152 | 4 | PF00685 | |
| Domain | Sulfotransferase_dom | 2.03e-04 | 36 | 152 | 4 | IPR000863 | |
| Domain | IBN_N | 2.74e-04 | 16 | 152 | 3 | SM00913 | |
| Domain | Importin-beta_N | 3.30e-04 | 17 | 152 | 3 | IPR001494 | |
| Domain | SHR-BD | 3.91e-04 | 4 | 152 | 2 | IPR009543 | |
| Domain | VPS13_C | 3.91e-04 | 4 | 152 | 2 | PF16909 | |
| Domain | VPS13_C | 3.91e-04 | 4 | 152 | 2 | IPR031645 | |
| Domain | SHR-BD | 3.91e-04 | 4 | 152 | 2 | PF06650 | |
| Domain | ZF_ZZ_2 | 3.94e-04 | 18 | 152 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 3.94e-04 | 18 | 152 | 3 | PS01357 | |
| Domain | ZZ | 3.94e-04 | 18 | 152 | 3 | PF00569 | |
| Domain | SH3 | 3.97e-04 | 216 | 152 | 8 | SM00326 | |
| Domain | SH3 | 3.97e-04 | 216 | 152 | 8 | PS50002 | |
| Domain | SH3_domain | 4.48e-04 | 220 | 152 | 8 | IPR001452 | |
| Domain | Znf_ZZ | 4.65e-04 | 19 | 152 | 3 | IPR000433 | |
| Domain | ZnF_ZZ | 4.65e-04 | 19 | 152 | 3 | SM00291 | |
| Domain | CRIB | 5.44e-04 | 20 | 152 | 3 | PS50108 | |
| Domain | CRIB_dom | 6.31e-04 | 21 | 152 | 3 | IPR000095 | |
| Domain | DOCK_N | 6.47e-04 | 5 | 152 | 2 | PF16172 | |
| Domain | DOCK_N | 6.47e-04 | 5 | 152 | 2 | IPR032376 | |
| Domain | FATC | 6.47e-04 | 5 | 152 | 2 | PF02260 | |
| Domain | Pkinase_Tyr | 6.58e-04 | 129 | 152 | 6 | PF07714 | |
| Domain | Tyr_kinase_cat_dom | 7.61e-04 | 88 | 152 | 5 | IPR020635 | |
| Domain | TyrKc | 7.61e-04 | 88 | 152 | 5 | SM00219 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 9.36e-04 | 138 | 152 | 6 | IPR001245 | |
| Domain | FAT | 9.66e-04 | 6 | 152 | 2 | PS51189 | |
| Domain | FATC | 9.66e-04 | 6 | 152 | 2 | PS51190 | |
| Domain | FATC_dom | 9.66e-04 | 6 | 152 | 2 | IPR003152 | |
| Domain | PIK_FAT | 9.66e-04 | 6 | 152 | 2 | IPR014009 | |
| Domain | FATC | 9.66e-04 | 6 | 152 | 2 | SM01343 | |
| Domain | PROTEIN_KINASE_TYR | 1.18e-03 | 97 | 152 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.18e-03 | 97 | 152 | 5 | IPR008266 | |
| Domain | Spectrin_repeat | 1.65e-03 | 29 | 152 | 3 | IPR002017 | |
| Domain | Chorein_N | 1.78e-03 | 8 | 152 | 2 | PF12624 | |
| Domain | VPS13_N | 1.78e-03 | 8 | 152 | 2 | IPR026854 | |
| Domain | SPEC | 2.20e-03 | 32 | 152 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.20e-03 | 32 | 152 | 3 | IPR018159 | |
| Domain | SH3_1 | 2.26e-03 | 164 | 152 | 6 | PF00018 | |
| Domain | HEAT_REPEAT | 2.55e-03 | 70 | 152 | 4 | PS50077 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 2.16e-08 | 5 | 116 | 4 | M47807 | |
| Pathway | KEGG_SULFUR_METABOLISM | 2.94e-06 | 13 | 116 | 4 | M18256 | |
| Pathway | BIOCARTA_MET_PATHWAY | 6.83e-06 | 33 | 116 | 5 | M19358 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 7.96e-06 | 34 | 116 | 5 | M3342 | |
| Pathway | WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING | 7.96e-06 | 34 | 116 | 5 | M39383 | |
| Pathway | PID_FAK_PATHWAY | 8.61e-06 | 59 | 116 | 6 | M281 | |
| Pathway | PID_FCER1_PATHWAY | 9.50e-06 | 60 | 116 | 6 | M7 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 1.22e-05 | 37 | 116 | 5 | MM15022 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 1.45e-05 | 134 | 116 | 8 | M3574 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 2.31e-05 | 42 | 116 | 5 | M27308 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 2.34e-05 | 21 | 116 | 4 | MM15633 | |
| Pathway | WP_ESTROGEN_METABOLISM | 2.84e-05 | 22 | 116 | 4 | MM15888 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 2.84e-05 | 22 | 116 | 4 | M903 | |
| Pathway | WP_RETINOL_METABOLISM | 2.91e-05 | 44 | 116 | 5 | MM15851 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 2.95e-05 | 8 | 116 | 3 | MM15213 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 3.37e-05 | 110 | 116 | 7 | M48043 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 3.42e-05 | 23 | 116 | 4 | MM14597 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 4.07e-05 | 24 | 116 | 4 | M16289 | |
| Pathway | WP_IL3_SIGNALING | 4.94e-05 | 49 | 116 | 5 | M39722 | |
| Pathway | PID_IL2_1PATHWAY | 8.67e-05 | 55 | 116 | 5 | M122 | |
| Pathway | PID_PDGFRB_PATHWAY | 9.31e-05 | 129 | 116 | 7 | M186 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | DOCK1 DOCK3 VRK3 RASA1 NRG2 RAPGEF1 ATP6V0A4 DNM3 TNK2 LYN MAP2K1 MAP2K2 FYN EP300 | 1.18e-04 | 532 | 116 | 14 | M27870 |
| Pathway | WP_KIT_RECEPTOR_SIGNALING | 1.22e-04 | 59 | 116 | 5 | M39350 | |
| Pathway | PID_NETRIN_PATHWAY | 1.31e-04 | 32 | 116 | 4 | M108 | |
| Pathway | WP_B_CELL_RECEPTOR_SIGNALING | 1.47e-04 | 97 | 116 | 6 | M39323 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 1.48e-04 | 33 | 116 | 4 | MM1426 | |
| Pathway | BIOCARTA_MET_PATHWAY | 1.48e-04 | 33 | 116 | 4 | MM1494 | |
| Pathway | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | 1.85e-04 | 14 | 116 | 3 | M622 | |
| Pathway | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | 1.85e-04 | 14 | 116 | 3 | MM14667 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 1.93e-04 | 65 | 116 | 5 | MM14911 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.93e-04 | 102 | 116 | 6 | MM15830 | |
| Pathway | PID_GMCSF_PATHWAY | 2.09e-04 | 36 | 116 | 4 | M22 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 2.87e-04 | 39 | 116 | 4 | MM15695 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 2.92e-04 | 71 | 116 | 5 | MM15947 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.03e-04 | 261 | 116 | 9 | MM15676 | |
| Pathway | WP_IL5_SIGNALING | 3.16e-04 | 40 | 116 | 4 | M39392 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 3.39e-04 | 17 | 116 | 3 | MM15215 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 3.39e-04 | 17 | 116 | 3 | M39483 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 3.49e-04 | 41 | 116 | 4 | MM15162 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 3.49e-04 | 41 | 116 | 4 | MM15630 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 3.77e-04 | 75 | 116 | 5 | MM14652 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 3.83e-04 | 42 | 116 | 4 | M41821 | |
| Pathway | WP_IL2_SIGNALING | 3.83e-04 | 42 | 116 | 4 | M39536 | |
| Pathway | WP_IL7_SIGNALING_PATHWAY | 4.19e-04 | 43 | 116 | 4 | MM15864 | |
| Pathway | KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY | 4.80e-04 | 79 | 116 | 5 | M11816 | |
| Pathway | WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING | 5.91e-04 | 47 | 116 | 4 | M39380 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 6.41e-04 | 48 | 116 | 4 | M914 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 6.48e-04 | 21 | 116 | 3 | M27485 | |
| Pathway | WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN | 6.48e-04 | 21 | 116 | 3 | M48342 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | DOCK1 VRK3 RASA1 RAPGEF1 ATP6V0A4 TNK2 LYN MAP2K1 MAP2K2 FYN EP300 | 6.57e-04 | 418 | 116 | 11 | MM15587 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_BRAF_TO_ERK_SIGNALING_PATHWAY | 6.61e-04 | 5 | 116 | 2 | M49016 | |
| Pathway | REACTOME_NTRK2_ACTIVATES_RAC1 | 6.61e-04 | 5 | 116 | 2 | M27913 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_LMP2A_TO_PI3K_SIGNALING_PATHWAY | 6.61e-04 | 5 | 116 | 2 | M48997 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 7.47e-04 | 87 | 116 | 5 | MM15915 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 7.87e-04 | 88 | 116 | 5 | M41810 | |
| Pathway | WP_FOCAL_ADHESION | 8.93e-04 | 187 | 116 | 7 | MM15913 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 9.63e-04 | 92 | 116 | 5 | M27201 | |
| Pathway | SA_B_CELL_RECEPTOR_COMPLEXES | 9.69e-04 | 24 | 116 | 3 | M17200 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 9.85e-04 | 6 | 116 | 2 | M27559 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 9.85e-04 | 6 | 116 | 2 | MM15273 | |
| Pathway | REACTOME_FLT3_SIGNALING_THROUGH_SRC_FAMILY_KINASES | 9.85e-04 | 6 | 116 | 2 | M41736 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPP_J_TO_TLR2_4_MAPK_SIGNALING_PATHWAY | 9.85e-04 | 6 | 116 | 2 | M47636 | |
| Pathway | WP_ARYLAMINE_METABOLISM | 9.85e-04 | 6 | 116 | 2 | M39437 | |
| Pathway | REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS | 1.09e-03 | 25 | 116 | 3 | MM15172 | |
| Pathway | WP_IL7_SIGNALING | 1.09e-03 | 25 | 116 | 3 | M39499 | |
| Pathway | REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS | 1.23e-03 | 26 | 116 | 3 | M27424 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 1.23e-03 | 26 | 116 | 3 | M39687 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 1.23e-03 | 26 | 116 | 3 | MM14716 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.23e-03 | 26 | 116 | 3 | M27483 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 1.23e-03 | 26 | 116 | 3 | MM15896 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN | 1.37e-03 | 7 | 116 | 2 | M27912 | |
| Pathway | WP_IL3_SIGNALING_PATHWAY | 1.40e-03 | 100 | 116 | 5 | MM15879 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 1.40e-03 | 100 | 116 | 5 | MM15826 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.53e-03 | 102 | 116 | 5 | M39577 | |
| Pathway | PID_TRKR_PATHWAY | 1.58e-03 | 61 | 116 | 4 | M187 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 1.65e-03 | 153 | 116 | 6 | MM15844 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.65e-03 | 153 | 116 | 6 | MM15522 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 1.70e-03 | 29 | 116 | 3 | MM1356 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 1.70e-03 | 29 | 116 | 3 | M13494 | |
| Pathway | REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS | 1.70e-03 | 29 | 116 | 3 | M27431 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.70e-03 | 29 | 116 | 3 | M45015 | |
| Pathway | REACTOME_SIGNALING_BY_INTERLEUKINS | VRK3 GATA3 RAPGEF1 PSMD1 PTPN4 PTPN14 SYK LYN MAP2K1 FYN CNTF | 1.78e-03 | 473 | 116 | 11 | M874 |
| Pathway | REACTOME_SIGNALING_BY_NTRK1_TRKA | 1.78e-03 | 63 | 116 | 4 | MM14714 | |
| Pathway | PID_BCR_5PATHWAY | 1.78e-03 | 63 | 116 | 4 | M10 | |
| Pathway | BIOCARTA_EPHA4_PATHWAY | 1.82e-03 | 8 | 116 | 2 | M16334 | |
| Pathway | PID_EPHRINB_REV_PATHWAY | 1.87e-03 | 30 | 116 | 3 | M257 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 2.26e-03 | 32 | 116 | 3 | MM1355 | |
| Pathway | PID_ALPHA_SYNUCLEIN_PATHWAY | 2.26e-03 | 32 | 116 | 3 | M275 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 2.31e-03 | 112 | 116 | 5 | MM15214 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 2.33e-03 | 9 | 116 | 2 | M47852 | |
| Pathway | BIOCARTA_EPHA4_PATHWAY | 2.33e-03 | 9 | 116 | 2 | MM1388 | |
| Pathway | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | 2.33e-03 | 9 | 116 | 2 | MM15059 | |
| Pathway | WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1 | 2.33e-03 | 9 | 116 | 2 | M39481 | |
| Pathway | WP_IL5_SIGNALING_PATHWAY | 2.36e-03 | 68 | 116 | 4 | MM15930 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 2.47e-03 | 33 | 116 | 3 | M9494 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 2.49e-03 | 114 | 116 | 5 | MM14814 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 2.63e-03 | 70 | 116 | 4 | M13266 | |
| Pathway | REACTOME_PARASITE_INFECTION | 2.69e-03 | 116 | 116 | 5 | M29843 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 2.70e-03 | 34 | 116 | 3 | M13881 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 2.70e-03 | 34 | 116 | 3 | MM15025 | |
| Pubmed | SHANK1 DOCK1 RAPGEF1 PSMD1 ACTN1 CDC42EP1 HIPK3 CSE1L SF3B1 MAP4K5 MCM3AP DIAPH2 ANKRD17 TNK2 DMD MAP2K1 MAP2K2 EP300 | 9.66e-12 | 486 | 157 | 18 | 20936779 | |
| Pubmed | FBL STRBP NPEPPS SMCHD1 INTS1 PSMD1 ACTN1 ACTR3 CRNKL1 USP5 IGF2BP3 CSE1L SF3B1 XPO5 MCM3AP RBM6 ZNF638 EIF5B ANKRD17 | 1.53e-10 | 653 | 157 | 19 | 22586326 | |
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 24318996 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 33414449 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 8943792 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 4.00e-10 | 4 | 157 | 4 | 12390022 | |
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 8424956 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 19900187 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 8288252 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 25370010 | ||
| Pubmed | 1.99e-09 | 5 | 157 | 4 | 11389699 | ||
| Pubmed | 1.99e-09 | 5 | 157 | 4 | 29908303 | ||
| Pubmed | Tyrosine phosphorylation of p190 RhoGAP by Fyn regulates oligodendrocyte differentiation. | 1.99e-09 | 5 | 157 | 4 | 11536198 | |
| Pubmed | 1.99e-09 | 5 | 157 | 4 | 25053625 | ||
| Pubmed | 1.99e-09 | 5 | 157 | 4 | 24802129 | ||
| Pubmed | CDC42BPG VRK3 FBL NPEPPS PSMD1 ACTR3 ADD1 CRNKL1 FARSA EEF2 IGF2BP3 PTPN14 CSE1L SF3B1 WDR87 SEC24B EIF5B ANKRD17 MLLT6 LYN MAP2K1 MAP2K2 FYN | 1.08e-08 | 1247 | 157 | 23 | 27684187 | |
| Pubmed | 1.38e-08 | 7 | 157 | 4 | 12438748 | ||
| Pubmed | 1.38e-08 | 7 | 157 | 4 | 9370299 | ||
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 2.76e-08 | 8 | 157 | 4 | 10594240 | |
| Pubmed | KDM3A FBL SMCHD1 ACTN1 ADD1 ADD3 SCYL2 PTPN14 ZZZ3 AMOT TET1 SEC24B KDM6A EP300 DCAF7 | 3.32e-08 | 549 | 157 | 15 | 38280479 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | EPHB2 SMG1 ATR INTS1 HIPK3 PHKA2 MAP4K5 SYK DNM3 EIF5B TNK2 LYN PDCD10 MAP2K1 MAP2K2 FYN MRPL1 EP300 DCAF7 | 3.37e-08 | 910 | 157 | 19 | 36736316 |
| Pubmed | 4.95e-08 | 9 | 157 | 4 | 8887328 | ||
| Pubmed | Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis. | 4.95e-08 | 9 | 157 | 4 | 23207770 | |
| Pubmed | 4.95e-08 | 9 | 157 | 4 | 19548878 | ||
| Pubmed | 4.95e-08 | 9 | 157 | 4 | 9177785 | ||
| Pubmed | 4.95e-08 | 9 | 157 | 4 | 9166597 | ||
| Pubmed | 4.95e-08 | 9 | 157 | 4 | 8468045 | ||
| Pubmed | Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases. | 4.95e-08 | 9 | 157 | 4 | 9060415 | |
| Pubmed | 6.74e-08 | 78 | 157 | 7 | 17192257 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | SMCHD1 CRNKL1 USP5 CSE1L SF3B1 XPO5 SMARCD2 KDM6A EP300 DCAF7 | 6.96e-08 | 220 | 157 | 10 | 35785414 |
| Pubmed | 8.22e-08 | 10 | 157 | 4 | 7601475 | ||
| Pubmed | Immunofluorescence localization of an adducin-like protein in the chromosomes of mouse oocytes. | 9.02e-08 | 3 | 157 | 3 | 1864459 | |
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 15834281 | ||
| Pubmed | Targeted disruption of the beta adducin gene (Add2) causes red blood cell spherocytosis in mice. | 9.02e-08 | 3 | 157 | 3 | 10485892 | |
| Pubmed | Identification of two human brain aryl sulfotransferase cDNAs. | 9.02e-08 | 3 | 157 | 3 | 8363592 | |
| Pubmed | Role of the adducin family genes in human essential hypertension. | 9.02e-08 | 3 | 157 | 3 | 15716695 | |
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 9855620 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 8912648 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 18667944 | ||
| Pubmed | Arterial properties in relation to genetic variations in the adducin subunits in a white population. | 9.02e-08 | 3 | 157 | 3 | 18787518 | |
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 21749309 | ||
| Pubmed | Localization of the murine cholecystokinin A and B receptor genes. | 1.29e-07 | 11 | 157 | 4 | 7613026 | |
| Pubmed | 1.29e-07 | 11 | 157 | 4 | 11154739 | ||
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 1.29e-07 | 11 | 157 | 4 | 8954725 | |
| Pubmed | Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. | 1.29e-07 | 11 | 157 | 4 | 9034160 | |
| Pubmed | 1.29e-07 | 11 | 157 | 4 | 10720750 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CCP110 CDH23 ACTN1 ACTR3 SYDE1 RSPRY1 SCYL2 PTPN14 CSE1L XPO5 KLHL7 AMOT SEC24B PTPRQ DZIP3 WDR35 ZNF638 EIF5B LUM FGD6 RSPH10B DCAF7 | 1.38e-07 | 1321 | 157 | 22 | 27173435 |
| Pubmed | 1.92e-07 | 12 | 157 | 4 | 8621719 | ||
| Pubmed | Identification of four chromosomal loci determining obesity in a multifactorial mouse model. | 1.92e-07 | 12 | 157 | 4 | 7706460 | |
| Pubmed | KDM3A STRBP LRP1B HIPK3 BMI1 SULT1A2 BMPR1B KLK4 SULT1A4 SULT1A1 SULT1A3 LYN MAP2K1 MAP2K2 FYN EP300 | 2.30e-07 | 730 | 157 | 16 | 34857952 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FBL SMCHD1 ACTN1 ACTR3 ADD1 ADD3 METTL14 CRNKL1 FARSA EEF2 PTPN14 CSE1L SF3B1 KLHL7 ZNF638 EIF5B ANKRD17 SMARCD2 SLC7A5 LYN DCAF7 | 2.59e-07 | 1257 | 157 | 21 | 36526897 |
| Pubmed | 2.77e-07 | 13 | 157 | 4 | 10585447 | ||
| Pubmed | Structural and chemical profiling of the human cytosolic sulfotransferases. | 2.77e-07 | 13 | 157 | 4 | 17425406 | |
| Pubmed | p21rasGAP association with Fyn, Lyn, and Yes in thrombin-activated platelets. | 3.60e-07 | 4 | 157 | 3 | 1544885 | |
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 32152050 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 12563261 | ||
| Pubmed | SMG1 STRBP SMCHD1 GATA3 PSMD1 FIGN ACTR3 IGF2BP3 ZZZ3 CSE1L SEC24B EPC1 RBM6 ZNF638 ANKRD17 SMARCD2 MLLT6 KDM6A MRPL1 EP300 INO80B DCAF7 | 5.21e-07 | 1429 | 157 | 22 | 35140242 | |
| Pubmed | 5.25e-07 | 15 | 157 | 4 | 1741163 | ||
| Pubmed | 5.25e-07 | 15 | 157 | 4 | 10790433 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | VRK3 FBL SMCHD1 INTS1 ACTR3 ADD1 ADD2 CRNKL1 FARSA EEF2 IGF2BP3 SF3B1 XPO5 KLHL7 EIF5B SMARCD2 LYN MAP2K1 MAP2K2 MRPL1 DCAF7 | 5.60e-07 | 1318 | 157 | 21 | 30463901 |
| Pubmed | Global phosphoproteome analysis on human HepG2 hepatocytes using reversed-phase diagonal LC. | 5.92e-07 | 36 | 157 | 5 | 16097034 | |
| Pubmed | DOCK1 PSMD1 ADD1 ADD2 CDC42EP1 SCYL2 FARSA EEF2 CSE1L XPO5 MAP4K5 SEC24B EIF5B ANKRD17 EIF2AK3 | 8.52e-07 | 708 | 157 | 15 | 39231216 | |
| Pubmed | Pin1 links the activities of c-Abl and p300 in regulating p73 function. | 8.97e-07 | 5 | 157 | 3 | 15175157 | |
| Pubmed | Insulin potentiates FcepsilonRI-mediated signaling in mouse bone marrow-derived mast cells. | 8.97e-07 | 5 | 157 | 3 | 20004975 | |
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 8395016 | ||
| Pubmed | Scaffolding adapter Grb2-associated binder 2 requires Syk to transmit signals from FcepsilonRI. | 8.97e-07 | 5 | 157 | 3 | 16456001 | |
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 19362019 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | NPEPPS PCLO ACTN1 TLR8 ADD1 ADD2 ADD3 USP5 EEF2 ADAMTS20 LYN MAP2K1 FYN KDM6A | 9.74e-07 | 621 | 157 | 14 | 22794259 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | ATR STRBP SMCHD1 GATA3 ADD1 ADD3 IGF2BP3 CSE1L ZNF638 MAP2K1 MAP2K2 | 1.07e-06 | 370 | 157 | 11 | 22922362 |
| Pubmed | 1.16e-06 | 18 | 157 | 4 | 20056724 | ||
| Pubmed | FBL PSMD1 ACTN1 ADD1 ADD3 SCYL2 CRNKL1 USP5 EEF2 CSE1L SF3B1 XPO5 EIF5B MAP2K2 | 1.34e-06 | 638 | 157 | 14 | 33239621 | |
| Pubmed | FBL NPEPPS PSMD1 SCYL2 FARSA EEF2 IGF2BP3 CSE1L SF3B1 XPO5 MAP2K1 | 1.49e-06 | 383 | 157 | 11 | 29331416 | |
| Pubmed | Activated Fyn phosphorylates alpha-synuclein at tyrosine residue 125. | 1.79e-06 | 6 | 157 | 3 | 11162638 | |
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 21098033 | ||
| Pubmed | Activation of Pyk2/RAFTK induces tyrosine phosphorylation of alpha-synuclein via Src-family kinases. | 1.79e-06 | 6 | 157 | 3 | 12096713 | |
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 11744621 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DIP2B CCP110 SYDE1 CDC42EP1 VPS13D PTPN14 MTUS1 AASS AMOT TET1 SEC24B ANKRD17 MAP2K1 MAP2K2 FGD6 DCAF7 | 1.99e-06 | 861 | 157 | 16 | 36931259 |
| Pubmed | 2.25e-06 | 21 | 157 | 4 | 32301970 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | DIP2B KDM3A ATR PSMD1 ADD1 EEF2 SF3B1 RBM6 ZNF638 EIF5B ANKRD17 SLC7A5 MAP2K2 KDM6A AGTPBP1 | 2.55e-06 | 774 | 157 | 15 | 15302935 |
| Pubmed | DOCK1 DOCK3 RAPGEF1 PTPN4 MAP4K5 SCG2 SEC24B DNM3 SMARCD2 FYN | 2.75e-06 | 329 | 157 | 10 | 17474147 | |
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 8756631 | ||
| Pubmed | DOCK1 CCP110 PSMD1 USP5 EEF2 SF3B1 EPC1 RBM6 ZNF638 EIF5B SMARCD2 MAP2K2 | 3.36e-06 | 503 | 157 | 12 | 16964243 | |
| Pubmed | ATR SMCHD1 INTS1 METTL14 CRNKL1 USP5 FARSA EEF2 CSE1L SF3B1 PTGR1 XPO5 EIF5B SMARCD2 KDM6A EP300 DCAF7 | 3.73e-06 | 1014 | 157 | 17 | 32416067 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 CYP4V2 CDC42BPG DIP2B RASA1 NPEPPS VPS13C PSMD1 HIPK3 RANBP17 PTPN4 BMPR1B KLK4 ASMTL RBM6 ZNF638 ANKRD17 TNK2 MAP2K2 KDM6A EP300 | 3.84e-06 | 1489 | 157 | 21 | 28611215 |
| Pubmed | VRK3 FBL STRBP NPEPPS SMCHD1 ACTR3 ADD1 ADD3 CRNKL1 FARSA EEF2 IGF2BP3 CSE1L SF3B1 SULT1A1 MCM3AP ANKRD17 SMARCD2 AGTPBP1 DCAF7 | 4.04e-06 | 1371 | 157 | 20 | 36244648 | |
| Pubmed | 4.11e-06 | 202 | 157 | 8 | 24639526 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FBL STRBP NPEPPS SMCHD1 INTS1 PSMD1 ACTN1 ACTR3 CRNKL1 IGF2BP3 CSE1L SF3B1 AMOT ZNF638 EIF5B LYN FYN | 4.24e-06 | 1024 | 157 | 17 | 24711643 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | NPEPPS PSMD1 ACTN1 ACTR3 ADD1 ADD2 PHKA2 USP5 EEF2 IGF2BP3 CSE1L SF3B1 SULT1A1 XPO5 AMOT EIF5B ANKRD17 DCAF7 | 4.85e-06 | 1149 | 157 | 18 | 35446349 |
| Pubmed | 4.97e-06 | 8 | 157 | 3 | 9295288 | ||
| Pubmed | Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis. | 4.97e-06 | 8 | 157 | 3 | 16921024 | |
| Pubmed | Receptor association and tyrosine phosphorylation of S6 kinases. | 4.97e-06 | 8 | 157 | 3 | 16640565 | |
| Pubmed | Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. | 4.97e-06 | 8 | 157 | 3 | 9311917 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | CCP110 FBL ACTR3B ACTR3 SYDE1 ADD1 ADD3 CDC42EP1 SCYL2 MCM3AP SEC24B SNX18 EIF5B DMD MAP2K2 AGTPBP1 DCAF7 | 5.07e-06 | 1038 | 157 | 17 | 26673895 |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | KDM3A GRK4 PSMD1 FIGN ADD1 ADD2 CHRNG SCG2 MYO3B ZNF638 MRPL1 | 5.86e-06 | 442 | 157 | 11 | 15815621 |
| Pubmed | SHANK1 DOCK3 KDM3A APBA1 PSMD1 ACTN1 ACTR3B LRP1B ADD3 SCYL2 CRNKL1 EEF2 SF3B1 KLHL7 SCG2 DNM3 KDM6A EP300 AGTPBP1 | 5.94e-06 | 1285 | 157 | 19 | 35914814 | |
| Pubmed | 6.24e-06 | 152 | 157 | 7 | 34299191 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | DOCK1 NPEPPS HIPK3 PTPN4 VPS13D IGF2BP3 PTPN14 TET1 DIAPH2 SYK RBM6 MAP2K2 | 6.40e-06 | 536 | 157 | 12 | 15840001 |
| Pubmed | DOCK1 NPEPPS HIPK3 PTPN4 VPS13D IGF2BP3 PTPN14 TET1 DIAPH2 SYK RBM6 MAP2K2 | 6.65e-06 | 538 | 157 | 12 | 10512203 | |
| Pubmed | 7.43e-06 | 9 | 157 | 3 | 7682059 | ||
| Pubmed | ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling. | 7.43e-06 | 9 | 157 | 3 | 28086240 | |
| Interaction | SIRT7 interactions | ATR FBL STRBP NPEPPS SMCHD1 INTS1 PSMD1 ACTN1 ACTR3 CRNKL1 USP5 IGF2BP3 CSE1L SF3B1 XPO5 MCM3AP RBM6 ZNF638 EIF5B ANKRD17 DCAF7 | 2.47e-07 | 744 | 154 | 21 | int:SIRT7 |
| Interaction | AR interactions | CDC42BPG KDM3A RASA1 VPS13C SMCHD1 PSMD1 ACTR3 HIPK3 BMI1 CRNKL1 USP5 FARSA EEF2 CSE1L SF3B1 XPO5 EPC1 SYK SMARCD2 TNK2 LYN KDM6A EP300 DCAF7 | 5.27e-07 | 992 | 154 | 24 | int:AR |
| Interaction | RHOD interactions | FBL PSMD1 ACTN1 ADD1 ADD2 ADD3 CDC42EP1 BMPR1B CSE1L SULT1A1 XPO5 DIAPH2 SLC7A5 LYN MAP2K1 MAP2K2 EIF2AK3 | 1.88e-06 | 572 | 154 | 17 | int:RHOD |
| Interaction | RAC1 interactions | DOCK1 DOCK3 CDC42BPG STRBP MCF2 RAPGEF1 SYDE1 ADD1 ADD2 ADD3 CDC42EP1 EEF2 PTPN14 CSE1L XPO5 MAP4K5 MCM3AP DIAPH2 SLC7A5 LYN MAP2K1 MAP2K2 FYN | 6.09e-06 | 1063 | 154 | 23 | int:RAC1 |
| Interaction | ADD2 interactions | 7.25e-06 | 93 | 154 | 7 | int:ADD2 | |
| Interaction | SULT1C2 interactions | 1.16e-05 | 19 | 154 | 4 | int:SULT1C2 | |
| Interaction | FOXK1 interactions | BMI1 PHKA2 EEF2 AMOT DNAI2 KDM6A EIF2AK3 EP300 AGTPBP1 DCAF7 | 1.52e-05 | 238 | 154 | 10 | int:FOXK1 |
| Interaction | RHOF interactions | ATR FBL NPEPPS ACTN1 SYDE1 ADD1 ADD2 ADD3 CDC42EP1 CSE1L XPO5 DIAPH2 SLC7A5 LYN MAP2K1 MAP2K2 FYN | 1.60e-05 | 673 | 154 | 17 | int:RHOF |
| Interaction | TNK2 interactions | 1.96e-05 | 195 | 154 | 9 | int:TNK2 | |
| Interaction | CXADR interactions | DIP2B ADD1 ADD2 ADD3 CDC42EP1 PTPN14 AMOT MAP4K5 SEC24B SLC7A5 LYN FGD6 | 2.76e-05 | 369 | 154 | 12 | int:CXADR |
| Interaction | C11orf52 interactions | DIP2B ADD1 ADD2 ADD3 CDC42EP1 SCYL2 PTPN14 AMOT MAP4K5 SLC7A5 LYN | 2.81e-05 | 311 | 154 | 11 | int:C11orf52 |
| Interaction | RHOJ interactions | DIP2B VPS13C PSMD1 SYDE1 ADD1 ADD2 ADD3 CDC42EP1 SCYL2 BMPR1B PTPN14 CSE1L DIAPH2 EIF5B SLC7A5 LYN | 2.87e-05 | 633 | 154 | 16 | int:RHOJ |
| Interaction | SULT1A3 interactions | 3.09e-05 | 24 | 154 | 4 | int:SULT1A3 | |
| Interaction | RAB35 interactions | EPHB2 DIP2B VPS13C ADD1 ADD2 ADD3 CDC42EP1 SCYL2 BMI1 PTPN14 AMOT MAP4K5 SLC7A5 LYN EIF2AK3 | 3.46e-05 | 573 | 154 | 15 | int:RAB35 |
| Interaction | N4BP2 interactions | 6.22e-05 | 89 | 154 | 6 | int:N4BP2 | |
| Interaction | SULT1C3 interactions | 6.90e-05 | 11 | 154 | 3 | int:SULT1C3 | |
| Interaction | KSR1 interactions | 7.04e-05 | 132 | 154 | 7 | int:KSR1 | |
| Interaction | CALM1 interactions | DOCK3 CCP110 RASA1 VPS13C GRK4 SYDE1 ADD1 ADD2 BMI1 PHKA2 VPS13D SF3B1 MCM3AP SYK EIF5B | 9.37e-05 | 626 | 154 | 15 | int:CALM1 |
| Interaction | EED interactions | CDC42BPG FBL STRBP VPS13C SMCHD1 INTS1 PSMD1 ACTN1 ACTR3 BMI1 CRNKL1 USP5 FARSA EEF2 PTPN14 CSE1L SF3B1 XPO5 SEC24B EPC1 SNX18 ZNF638 EIF5B MAP2K1 DCAF7 | 9.88e-05 | 1445 | 154 | 25 | int:EED |
| Interaction | CD72 interactions | 9.98e-05 | 32 | 154 | 4 | int:CD72 | |
| Interaction | RHOV interactions | CDC42BPG CCP110 NPEPPS PSMD1 CDC42EP1 CSE1L XPO5 SLC7A5 MAP2K2 | 1.08e-04 | 243 | 154 | 9 | int:RHOV |
| Interaction | SPSB1 interactions | 1.13e-04 | 33 | 154 | 4 | int:SPSB1 | |
| Interaction | ROCK1 interactions | 1.17e-04 | 192 | 154 | 8 | int:ROCK1 | |
| Interaction | YWHAQ interactions | CCP110 CACNA1S VRK3 PSMD1 SYDE1 METTL14 CDC42EP1 PTPN4 EEF2 VPS13D IGF2BP3 PTPN14 CSE1L MTUS1 AASS TET1 ZNF638 ANKRD17 MAP2K1 MAP2K2 FGD6 | 1.24e-04 | 1118 | 154 | 21 | int:YWHAQ |
| Interaction | FOXP3 interactions | ATR STRBP SMCHD1 GATA3 ADD1 ADD3 IGF2BP3 CSE1L ZNF638 MAP2K1 MAP2K2 EP300 | 1.25e-04 | 432 | 154 | 12 | int:FOXP3 |
| Interaction | LYN interactions | CYP4V2 CCP110 SDK2 RASA1 CDH23 ADD1 ADD2 ADD3 CDC42EP1 PTPN14 MAP4K5 SYK SLC7A5 TNK2 DMD LYN | 1.30e-04 | 720 | 154 | 16 | int:LYN |
| Interaction | CRK interactions | EPHB2 DOCK1 DOCK3 CCP110 OFCC1 RAPGEF1 SCYL2 PTPN4 CSE1L MAP4K5 FYN | 1.33e-04 | 370 | 154 | 11 | int:CRK |
| Interaction | LAMTOR1 interactions | DIP2B CCP110 VPS13C ADD1 ADD3 CDC42EP1 SCYL2 SULT1A2 FARSA PTPN14 MAP4K5 DIAPH2 SLC7A5 DMD LYN FGD6 | 1.34e-04 | 722 | 154 | 16 | int:LAMTOR1 |
| Interaction | EPHB3 interactions | 1.43e-04 | 35 | 154 | 4 | int:EPHB3 | |
| Interaction | GRB2 interactions | EPHB2 DOCK1 RASA1 RAPGEF1 METTL14 HIPK3 USP5 EEF2 CSE1L MAP4K5 SNX18 SYK DNM3 TNK2 FYN FGD6 EP300 | 1.49e-04 | 806 | 154 | 17 | int:GRB2 |
| Interaction | SULT1A4 interactions | 1.50e-04 | 14 | 154 | 3 | int:SULT1A4 | |
| Interaction | RHOQ interactions | CDC42BPG VPS13C RAPGEF1 SYDE1 ADD1 ADD2 ADD3 CDC42EP1 SCYL2 DIAPH2 SLC7A5 LYN | 1.54e-04 | 442 | 154 | 12 | int:RHOQ |
| Interaction | BMI1 interactions | KDM3A FBL STRBP GATA3 ACTN1 BMI1 CRNKL1 IGF2BP3 SEC24B RBM6 ZNF638 SMARCD2 MAP2K1 KDM6A EP300 | 1.64e-04 | 659 | 154 | 15 | int:BMI1 |
| Interaction | CDC42 interactions | CDC42BPG ATR FBL MCF2 ACTR3 SYDE1 ADD3 CDC42EP1 YIF1A FARSA PTPN14 CSE1L SULT1A1 AASS MCM3AP DIAPH2 EIF5B SLC7A5 TNK2 LYN MAP2K2 FYN EIF2AK3 | 1.81e-04 | 1323 | 154 | 23 | int:CDC42 |
| Interaction | PLCG1 interactions | 2.01e-04 | 264 | 154 | 9 | int:PLCG1 | |
| Interaction | SOX2 interactions | VRK3 FBL NPEPPS SMCHD1 INTS1 ACTR3 SCYL2 BMI1 FARSA EEF2 XPO5 SNX18 ZNF638 EIF5B ANKRD17 SMARCD2 LUM FYN KDM6A MRPL1 EP300 RSPH10B TP73 DCAF7 | 2.01e-04 | 1422 | 154 | 24 | int:SOX2 |
| Interaction | RAC2 interactions | DOCK1 FBL INTS1 PSMD1 SYDE1 ADD1 ADD3 CDC42EP1 USP5 VPS13D DIAPH2 SLC7A5 LYN FYN EIF2AK3 | 2.10e-04 | 674 | 154 | 15 | int:RAC2 |
| Interaction | RHOB interactions | EPHB2 DOCK1 DIP2B SDK2 PSMD1 ADD3 CDC42EP1 SCYL2 FARSA PTPN14 CSE1L MAP4K5 DIAPH2 SLC7A5 LYN MAP2K1 FYN | 2.42e-04 | 840 | 154 | 17 | int:RHOB |
| Interaction | HSP90AA1 interactions | SMG1 VRK3 ATR GRK4 MCF2 PSMD1 ACTN1 METTL14 CRNKL1 EEF2 IGF2BP3 AASS WDR87 SCG2 MYO3B EIF5B TNK2 LYN MAP2K1 MAP2K2 FYN EIF2AK3 | 2.46e-04 | 1263 | 154 | 22 | int:HSP90AA1 |
| Interaction | HSF1 interactions | CHST10 FBL SMCHD1 PSMD1 RNF17 CC2D2B USP5 EEF2 CSE1L SF3B1 SEC24B EIF5B EP300 DCAF7 | 2.47e-04 | 609 | 154 | 14 | int:HSF1 |
| Interaction | STIP1 interactions | FBL GRK4 PSMD1 ACTN1 ADD1 ADD3 METTL14 SCYL2 CRNKL1 USP5 EEF2 PTPN14 CSE1L SF3B1 XPO5 DNAI2 EIF5B MAP2K2 EP300 | 2.49e-04 | 1006 | 154 | 19 | int:STIP1 |
| Interaction | AFDN interactions | 2.49e-04 | 333 | 154 | 10 | int:AFDN | |
| Interaction | PXN interactions | 2.55e-04 | 334 | 154 | 10 | int:PXN | |
| Interaction | SNAI1 interactions | FBL NPEPPS PSMD1 QRICH2 SCYL2 FARSA EEF2 IGF2BP3 CSE1L SF3B1 XPO5 MAP2K1 EP300 | 2.96e-04 | 546 | 154 | 13 | int:SNAI1 |
| GeneFamily | Sulfotransferases, cytosolic | 7.17e-07 | 14 | 96 | 4 | 762 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.12e-04 | 18 | 96 | 3 | 91 | |
| GeneFamily | Mitogen-activated protein kinase kinases | 5.76e-04 | 7 | 96 | 2 | 653 | |
| GeneFamily | Exportins | 5.76e-04 | 7 | 96 | 2 | 547 | |
| GeneFamily | SH2 domain containing | 2.06e-03 | 101 | 96 | 4 | 741 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPHB2 DOCK1 KDM3A ATR RASA1 NPEPPS SMCHD1 PTPN4 IGF2BP3 ZZZ3 CSE1L MAP4K5 SEC24B RBM6 ZNF638 ANKRD17 DMD LYN MAP2K1 FYN | 1.96e-07 | 856 | 156 | 20 | M4500 |
| Coexpression | VERNOCHET_ADIPOGENESIS | 2.72e-07 | 24 | 156 | 5 | MM1317 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ATR RASA1 NPEPPS SMCHD1 IGF2BP3 ZZZ3 MAP4K5 SEC24B RBM6 ZNF638 ANKRD17 LYN MAP2K1 FYN | 8.30e-07 | 466 | 156 | 14 | M13522 |
| Coexpression | INGRAM_SHH_TARGETS_UP | 4.53e-06 | 156 | 156 | 8 | MM550 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 5.79e-06 | 75 | 156 | 6 | MM1084 | |
| Coexpression | YANAGIHARA_ESX1_TARGETS | 2.55e-05 | 29 | 156 | 4 | M1538 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | 2.76e-05 | 200 | 156 | 8 | M8030 | |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN | 2.76e-05 | 200 | 156 | 8 | M7193 | |
| Coexpression | WELCSH_BRCA1_TARGETS_UP | 2.86e-05 | 201 | 156 | 8 | M5490 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP | 2.96e-05 | 202 | 156 | 8 | M38982 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SMG1 RASA1 NPEPPS INTS1 ADD1 ADD3 SCYL2 HIPK3 CSE1L MAP4K5 ASMTL DZIP3 SYK EIF5B ANKRD17 PDCD10 FYN KDM6A AGTPBP1 DCAF7 | 3.74e-05 | 1215 | 156 | 20 | M41122 |
| Coexpression | FIRESTEIN_PROLIFERATION | 6.36e-05 | 166 | 156 | 7 | M5354 | |
| Coexpression | WANG_SMARCE1_TARGETS_UP | 7.04e-05 | 294 | 156 | 9 | M1804 | |
| Coexpression | STEINER_ERYTHROCYTE_MEMBRANE_GENES | 7.17e-05 | 14 | 156 | 3 | M2442 | |
| Coexpression | GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_UP | 7.66e-05 | 171 | 156 | 7 | M6316 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD | 1.06e-04 | 125 | 156 | 6 | M38988 | |
| Coexpression | CORRE_MULTIPLE_MYELOMA_UP | 1.18e-04 | 80 | 156 | 5 | M13639 | |
| Coexpression | PARK_HSC_MARKERS | 1.36e-04 | 44 | 156 | 4 | M6509 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | ATR RASA1 NPEPPS ACTR3 BMI1 IGF2BP3 CSE1L MCM3AP SEC24B RBM6 ZNF638 | 1.52e-04 | 481 | 156 | 11 | M3898 |
| Coexpression | GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP | 1.90e-04 | 198 | 156 | 7 | M7948 | |
| Coexpression | GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_UP | 1.96e-04 | 199 | 156 | 7 | M7329 | |
| Coexpression | GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP | 1.96e-04 | 199 | 156 | 7 | M9238 | |
| Coexpression | GSE11924_TFH_VS_TH1_CD4_TCELL_UP | 1.96e-04 | 199 | 156 | 7 | M3151 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | 2.01e-04 | 338 | 156 | 9 | M17094 | |
| Coexpression | GSE27786_LIN_NEG_VS_ERYTHROBLAST_UP | 2.02e-04 | 200 | 156 | 7 | M4790 | |
| Coexpression | GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP | 2.02e-04 | 200 | 156 | 7 | M7195 | |
| Coexpression | GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP | 2.02e-04 | 200 | 156 | 7 | M3675 | |
| Coexpression | GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN | 2.02e-04 | 200 | 156 | 7 | M5059 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT | 2.05e-04 | 90 | 156 | 5 | M38984 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-08 | 185 | 157 | 9 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.72e-08 | 198 | 157 | 9 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-07 | 182 | 157 | 8 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-07 | 184 | 157 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-07 | 184 | 157 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-07 | 184 | 157 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 5.53e-07 | 199 | 157 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Macroglial|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 5.75e-07 | 200 | 157 | 8 | 46f99bed98da09e6d3f45d4443cbaa6b6c1589bb | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-06 | 163 | 157 | 7 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-06 | 163 | 157 | 7 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-06 | 176 | 157 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.95e-06 | 189 | 157 | 7 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 5.12e-06 | 190 | 157 | 7 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-06 | 190 | 157 | 7 | 36e83995021ba16690f84e2077a9e8baec547d05 | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 5.12e-06 | 190 | 157 | 7 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-06 | 190 | 157 | 7 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-06 | 190 | 157 | 7 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-06 | 190 | 157 | 7 | d26be9e1b676f750e716b91ebc3598fac3735612 | |
| ToppCell | IPF-Myeloid-ncMonocyte|IPF / Disease state, Lineage and Cell class | 5.49e-06 | 192 | 157 | 7 | e9fb8c57d8094f70fb492909b2bec40aa5f2e5b8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Macroglial-Astrocyte|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 7.16e-06 | 200 | 157 | 7 | 158ba898312c73bcb54c675a4860874a1dd58662 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.16e-06 | 200 | 157 | 7 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-05 | 142 | 157 | 6 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-05 | 142 | 157 | 6 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | Control-B_naive-12|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.01e-05 | 157 | 157 | 6 | 4803f601c1ba43260aa09172acc7964aac2c8ccf | |
| ToppCell | Control-B_naive-12|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.08e-05 | 158 | 157 | 6 | 41318f864770370ce77ed3fa4a84f76c0c22c482 | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.57e-05 | 164 | 157 | 6 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(II)|lymph-node_spleen / Manually curated celltypes from each tissue | 3.81e-05 | 176 | 157 | 6 | 5788dd5b23ebb52f19d3b5bdbcfe25dee349cf77 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-Gamma_Delta_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.05e-05 | 108 | 157 | 5 | 04bfb90634b691020f246a8afbebd3bf944d1e0e | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 180 | 157 | 6 | 87fb1fdbc49c808bb5f6fe9fb747057b45fa78d0 | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 4.74e-05 | 183 | 157 | 6 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.88e-05 | 184 | 157 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 5.03e-05 | 185 | 157 | 6 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.19e-05 | 186 | 157 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.19e-05 | 186 | 157 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.34e-05 | 187 | 157 | 6 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.34e-05 | 187 | 157 | 6 | 02e7246ef5ad41773d14426254e139b156d45c1d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-05 | 187 | 157 | 6 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | Immune-B_cell|World / Lineage, Cell type, age group and donor | 5.34e-05 | 187 | 157 | 6 | 795690c6306c366e733279491138d0cd9b469b21 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-05 | 187 | 157 | 6 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-05 | 187 | 157 | 6 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.34e-05 | 187 | 157 | 6 | 08c73d125e0638c9e9878165bba2442c266c8a48 | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 5.34e-05 | 187 | 157 | 6 | af1327559f7e01bec070881cae52834917c3da65 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.50e-05 | 188 | 157 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.50e-05 | 188 | 157 | 6 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-05 | 188 | 157 | 6 | 40ce7125fca6f6b6b5cc1637c87d43c29b08f4f1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-05 | 188 | 157 | 6 | ba7f7ce034c0f42742bf2461f68f8d343ee593a5 | |
| ToppCell | IPF-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 5.67e-05 | 189 | 157 | 6 | 5c22d2d935f7bb270260b8bc6be67b565ec401bf | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.83e-05 | 190 | 157 | 6 | 424550418c1bd4eb070cf3c41cf09fa9d89aef37 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-05 | 191 | 157 | 6 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-05 | 191 | 157 | 6 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-05 | 191 | 157 | 6 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-05 | 191 | 157 | 6 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.18e-05 | 192 | 157 | 6 | 40f44ac4ab673ee6156abdd2074a60b9de3281ad | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.36e-05 | 193 | 157 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.36e-05 | 193 | 157 | 6 | 263d185af6ed80e639f864e4966268e0862c61dc | |
| ToppCell | COPD-Myeloid-ncMonocyte|COPD / Disease state, Lineage and Cell class | 6.36e-05 | 193 | 157 | 6 | 936ca95995599356b794fba32bfd82d8de339365 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.55e-05 | 194 | 157 | 6 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.55e-05 | 194 | 157 | 6 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 194 | 157 | 6 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 194 | 157 | 6 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 194 | 157 | 6 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 194 | 157 | 6 | 4d6c9b016e3a0641954a8ea10c97d1cd76fadd9f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 194 | 157 | 6 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.74e-05 | 195 | 157 | 6 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | Control-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 6.74e-05 | 195 | 157 | 6 | b4444b67a709e82b8e2ee510924c3152cb88b051 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-05 | 197 | 157 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-05 | 197 | 157 | 6 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | systemic_lupus_erythematosus-treated|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.33e-05 | 198 | 157 | 6 | 8165ff735095c52994fb5057d89be93cc378b7da | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.33e-05 | 198 | 157 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 7.53e-05 | 199 | 157 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 7.53e-05 | 199 | 157 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 7.53e-05 | 199 | 157 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.75e-05 | 200 | 157 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Lymphocytic-B_cells|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.75e-05 | 200 | 157 | 6 | 2fb3cf5c7a03c3874390a111bba15203599d4859 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Lymphocytic-B_cells-B-cells|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.75e-05 | 200 | 157 | 6 | 4c8007a158f0f6b6fa259b25d2387b648bb2fc0d | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.75e-05 | 200 | 157 | 6 | fc061de0db2e8b5ca47f5e2a1e861018e7f1b582 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-immature_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 132 | 157 | 5 | 9936078c328b1e1d59f9dfdd69d36926a0cdaf0d | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)-(3)_72hpi|(01)_Cycling_Basal_(homeostasis) / shred by cell type and Timepoint | 1.28e-04 | 28 | 157 | 3 | ef8053df22b28c772eb39c5e4033f96eb5aa54d9 | |
| ToppCell | remission-multiplets|remission / disease stage, cell group and cell class | 1.85e-04 | 149 | 157 | 5 | e9974260a5f2999b363f306cae005698c912893a | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.85e-04 | 149 | 157 | 5 | 65778f19599b4955c0a16f0121237656449431fb | |
| Drug | dopamine-4-O-sulfate | 7.49e-08 | 7 | 157 | 4 | CID000123932 | |
| Drug | 2-naphthylsulfate | 7.49e-08 | 7 | 157 | 4 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 7.49e-08 | 7 | 157 | 4 | CID003035977 | |
| Drug | luciferyl sulfate | 7.49e-08 | 7 | 157 | 4 | CID011953812 | |
| Drug | dopamine 3-O-sulfate | 1.49e-07 | 8 | 157 | 4 | CID000122136 | |
| Drug | 6-anilino-2-thiouracil | 1.49e-07 | 8 | 157 | 4 | CID003037707 | |
| Drug | 2-iodophenol | 1.49e-07 | 8 | 157 | 4 | CID000010784 | |
| Drug | EM-139 | 1.48e-06 | 13 | 157 | 4 | CID000131427 | |
| Drug | naphthalenemethanol | 2.06e-06 | 14 | 157 | 4 | CID000020908 | |
| Drug | deoxoestrone | 2.06e-06 | 14 | 157 | 4 | CID000005888 | |
| Drug | A2'p5'A2'p5'A | 2.15e-06 | 31 | 157 | 5 | CID000122642 | |
| Drug | EKB-569 | 2.39e-06 | 87 | 157 | 7 | CID006445562 | |
| Drug | arylsulfate | 2.80e-06 | 15 | 157 | 4 | CID000074426 | |
| Drug | cyclobenzaprine | 2.80e-06 | 15 | 157 | 4 | CID000002895 | |
| Drug | DCNP | 2.97e-06 | 33 | 157 | 5 | CID000012066 | |
| Drug | A-44 | 3.71e-06 | 16 | 157 | 4 | CID000120353 | |
| Drug | benzilic acid | 4.83e-06 | 17 | 157 | 4 | CID000006463 | |
| Drug | AC1Q6OHG | 7.78e-06 | 19 | 157 | 4 | CID000115063 | |
| Drug | pedunculagin | 7.78e-06 | 19 | 157 | 4 | CID000442688 | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 8.76e-06 | 195 | 157 | 9 | 2311_DN | |
| Drug | PLP-Glu | 9.67e-06 | 20 | 157 | 4 | CID000444293 | |
| Drug | Phosphoadenosine Phosphosulfate | 1.10e-05 | 7 | 157 | 3 | ctd:D010724 | |
| Drug | N-hydroxy-2-aminofluorene | 1.19e-05 | 21 | 157 | 4 | CID000005895 | |
| Drug | Apigenin | 1.41e-05 | 207 | 157 | 9 | ctd:D047310 | |
| Drug | MeA alpha C | 1.44e-05 | 22 | 157 | 4 | CID000062244 | |
| Drug | AABSSN | 1.44e-05 | 22 | 157 | 4 | CID005464134 | |
| Drug | PD158780 | 1.60e-05 | 46 | 157 | 5 | CID000004707 | |
| Drug | gallic acid | 1.61e-05 | 116 | 157 | 7 | CID000000370 | |
| Drug | taselin | 1.74e-05 | 23 | 157 | 4 | CID000023846 | |
| Drug | N-hydroxy-4-aminobiphenyl | 1.76e-05 | 8 | 157 | 3 | ctd:C014593 | |
| Drug | AalphaC | 2.08e-05 | 24 | 157 | 4 | CID000062805 | |
| Drug | phenylglyoxal | 2.12e-05 | 121 | 157 | 7 | CID000014090 | |
| Drug | AzMC | 2.46e-05 | 25 | 157 | 4 | CID000064986 | |
| Drug | minoxidil sulphate | 2.46e-05 | 25 | 157 | 4 | CID000004202 | |
| Drug | 2-pentanone | 2.46e-05 | 25 | 157 | 4 | CID000007895 | |
| Drug | alpha-methyldopamine | 2.89e-05 | 26 | 157 | 4 | CID000017005 | |
| Drug | glycolithocholic acid | 2.89e-05 | 26 | 157 | 4 | CID000115245 | |
| Drug | 1m2q | 2.89e-05 | 26 | 157 | 4 | CID005326637 | |
| Drug | MeIQx | 3.85e-05 | 55 | 157 | 5 | CID000062275 | |
| Drug | 0173570-0000 [211245-44-2]; Down 200; 10uM; PC3; HT_HG-U133A | 4.12e-05 | 183 | 157 | 8 | 7389_DN | |
| Drug | Glu-P-2 | 4.52e-05 | 29 | 157 | 4 | CID000049970 | |
| Drug | 2-naphthol | 4.54e-05 | 93 | 157 | 6 | CID000008663 | |
| Drug | imatinib | EPHB2 CCP110 ADD3 PKMYT1 BMPR1B TNK2 LYN MAP2K1 MAP2K2 FYN CNTF TP73 | 4.57e-05 | 430 | 157 | 12 | CID000005291 |
| Drug | TAK 733 | 4.72e-05 | 2 | 157 | 2 | ctd:C558666 | |
| Drug | Hydroxytryptophol | 4.72e-05 | 2 | 157 | 2 | ctd:D006917 | |
| Drug | 5-hydroxymethylfurfural | 4.72e-05 | 2 | 157 | 2 | ctd:C008046 | |
| Drug | 6-hydroxymelatonin | 4.72e-05 | 2 | 157 | 2 | ctd:C012365 | |
| Drug | N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide | 4.72e-05 | 2 | 157 | 2 | ctd:C544830 | |
| Drug | NSC36919 | 4.99e-05 | 58 | 157 | 5 | CID000235496 | |
| Drug | 3,3'-T2 | 5.19e-05 | 30 | 157 | 4 | CID000065559 | |
| Drug | aniline | 5.92e-05 | 142 | 157 | 7 | CID000006115 | |
| Drug | barium hydroxide | 5.92e-05 | 31 | 157 | 4 | CID000028387 | |
| Drug | acetaminophen sulfate | 5.92e-05 | 31 | 157 | 4 | CID000083939 | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; PC3; HT_HG-U133A | 6.22e-05 | 194 | 157 | 8 | 4572_DN | |
| Drug | 5252917; Down 200; 14uM; MCF7; HT_HG-U133A_EA | 6.45e-05 | 195 | 157 | 8 | 828_DN | |
| Drug | Orlistat; Up 200; 10uM; MCF7; HT_HG-U133A | 6.45e-05 | 195 | 157 | 8 | 6415_UP | |
| Drug | Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 6.45e-05 | 195 | 157 | 8 | 7426_DN | |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 1695_DN | |
| Drug | Ronidazole [7681-76-7]; Up 200; 20uM; PC3; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 7131_UP | |
| Drug | Antigens | 6.76e-05 | 12 | 157 | 3 | ctd:D000941 | |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; PC3; HG-U133A | 6.93e-05 | 197 | 157 | 8 | 1930_DN | |
| Drug | A21250 | 8.96e-05 | 105 | 157 | 6 | CID000000990 | |
| Drug | Quinoxalines | 1.11e-04 | 14 | 157 | 3 | ctd:D011810 | |
| Drug | 2-naphthylamine | 1.16e-04 | 110 | 157 | 6 | CID000007057 | |
| Drug | mefenamic acid | 1.20e-04 | 37 | 157 | 4 | CID000004044 | |
| Drug | phenylhydroxylamine | 1.34e-04 | 38 | 157 | 4 | CID000007518 | |
| Drug | 8-azaadenine | 1.41e-04 | 3 | 157 | 2 | ctd:C006654 | |
| Drug | 3,3'-diiodothyronine | 1.41e-04 | 3 | 157 | 2 | ctd:C030629 | |
| Drug | RO5126766 | 1.41e-04 | 3 | 157 | 2 | ctd:C577924 | |
| Drug | 5-hydroxy-3-methylindole | 1.41e-04 | 3 | 157 | 2 | CID000192734 | |
| Drug | 5-hydroxyindole | 1.41e-04 | 3 | 157 | 2 | ctd:C026785 | |
| Drug | Minoxidil | 1.41e-04 | 3 | 157 | 2 | ctd:D008914 | |
| Drug | daidzein | 1.64e-04 | 223 | 157 | 8 | ctd:C004742 | |
| Drug | d-equilenin | 1.81e-04 | 41 | 157 | 4 | CID000010597 | |
| Drug | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1.81e-04 | 41 | 157 | 4 | ctd:D019307 | |
| Drug | pentachlorophenol | 1.87e-04 | 120 | 157 | 6 | CID000000992 | |
| Drug | L-alpha-methyldopa | 1.99e-04 | 42 | 157 | 4 | CID000004138 | |
| Drug | polyproline | 2.16e-04 | 295 | 157 | 9 | CID000439587 | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; HL60; HT_HG-U133A | 2.18e-04 | 175 | 157 | 7 | 2485_UP | |
| Drug | Woodward's reagent K | 2.18e-04 | 43 | 157 | 4 | CID000077804 | |
| Drug | 4-hydroxyestradiol | 2.19e-04 | 79 | 157 | 5 | CID000001743 | |
| Drug | NSC674039 | 2.38e-04 | 44 | 157 | 4 | CID000001249 | |
| Drug | 4-hydroxypropranolol | 2.43e-04 | 18 | 157 | 3 | CID000091565 | |
| Drug | dimenhydrinate | 2.43e-04 | 18 | 157 | 3 | CID000010660 | |
| Drug | NDPS | 2.60e-04 | 45 | 157 | 4 | CID000090363 | |
| Drug | 1IIg | 2.60e-04 | 45 | 157 | 4 | CID000001682 | |
| Drug | Indiloy | 2.81e-04 | 4 | 157 | 2 | CID006367221 | |
| Drug | IDETA | 2.81e-04 | 4 | 157 | 2 | CID003036201 | |
| Drug | Chebi:32701 | 2.81e-04 | 4 | 157 | 2 | CID005460855 | |
| Disease | spastic quadriplegic cerebral palsy 3 (implicated_via_orthology) | 1.34e-07 | 3 | 152 | 3 | DOID:0081361 (implicated_via_orthology) | |
| Disease | rectum adenocarcinoma (is_marker_for) | 1.34e-07 | 3 | 152 | 3 | DOID:1996 (is_marker_for) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 8.20e-06 | 195 | 152 | 8 | DOID:1574 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 1.22e-05 | 206 | 152 | 8 | C0152013 | |
| Disease | cerebral palsy (implicated_via_orthology) | 1.57e-05 | 10 | 152 | 3 | DOID:1969 (implicated_via_orthology) | |
| Disease | colon cancer (is_implicated_in) | 3.51e-05 | 36 | 152 | 4 | DOID:219 (is_implicated_in) | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 7.88e-05 | 3 | 152 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | small intestine adenocarcinoma (is_implicated_in) | 7.88e-05 | 3 | 152 | 2 | DOID:4906 (is_implicated_in) | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 1.22e-04 | 19 | 152 | 3 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 1.22e-04 | 19 | 152 | 3 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 1.22e-04 | 19 | 152 | 3 | C1275081 | |
| Disease | Costello syndrome (disorder) | 1.22e-04 | 19 | 152 | 3 | C0587248 | |
| Disease | prostate cancer (is_marker_for) | 1.63e-04 | 156 | 152 | 6 | DOID:10283 (is_marker_for) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.76e-04 | 301 | 152 | 8 | DOID:684 (is_marker_for) | |
| Disease | LEOPARD Syndrome | 1.92e-04 | 22 | 152 | 3 | C0175704 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 2.51e-04 | 24 | 152 | 3 | DOID:3907 (is_implicated_in) | |
| Disease | Noonan Syndrome | 2.51e-04 | 24 | 152 | 3 | C0028326 | |
| Disease | fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement | 2.61e-04 | 5 | 152 | 2 | EFO_0004307, EFO_0004465, EFO_0004466 | |
| Disease | coagulation factor IXAB measurement | 2.61e-04 | 5 | 152 | 2 | EFO_0020264 | |
| Disease | adenoid cystic carcinoma (is_implicated_in) | 2.61e-04 | 5 | 152 | 2 | DOID:0080202 (is_implicated_in) | |
| Disease | melanoma | 3.13e-04 | 248 | 152 | 7 | C0025202 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 3.63e-04 | 181 | 152 | 6 | DOID:684 (is_implicated_in) | |
| Disease | lung small cell carcinoma (is_implicated_in) | 3.99e-04 | 28 | 152 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | colorectal cancer (is_implicated_in) | 4.18e-04 | 121 | 152 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | cytotoxicity measurement, response to clozapine | 4.44e-04 | 29 | 152 | 3 | EFO_0006952, GO_0097338 | |
| Disease | colorectal cancer (implicated_via_orthology) | 4.91e-04 | 30 | 152 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | stomach cancer (is_implicated_in) | 5.30e-04 | 72 | 152 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | Adult T-Cell Lymphoma/Leukemia | 5.42e-04 | 31 | 152 | 3 | C0023493 | |
| Disease | glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement | 5.44e-04 | 7 | 152 | 2 | EFO_0800551 | |
| Disease | glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) measurement | 5.44e-04 | 7 | 152 | 2 | EFO_0800520 | |
| Disease | lung cancer (is_implicated_in) | 5.89e-04 | 74 | 152 | 4 | DOID:1324 (is_implicated_in) | |
| Disease | Urologic Neoplasms | 7.23e-04 | 8 | 152 | 2 | C0042076 | |
| Disease | Cancer of Urinary Tract | 7.23e-04 | 8 | 152 | 2 | C0751571 | |
| Disease | primary ovarian insufficiency (is_implicated_in) | 7.23e-04 | 8 | 152 | 2 | DOID:5426 (is_implicated_in) | |
| Disease | RASopathy (implicated_via_orthology) | 9.27e-04 | 9 | 152 | 2 | DOID:0080690 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | SHANK1 ABCA3 FPGS ZZZ3 CSE1L MCM3AP TENM1 DMD KDM6A EP300 AGTPBP1 | 1.07e-03 | 702 | 152 | 11 | C0009402 |
| Disease | glaucoma (is_implicated_in) | 1.15e-03 | 10 | 152 | 2 | DOID:1686 (is_implicated_in) | |
| Disease | beta-nerve growth factor measurement | 1.33e-03 | 42 | 152 | 3 | EFO_0008035 | |
| Disease | Noonan Syndrome 1 | 1.41e-03 | 11 | 152 | 2 | C4551602 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 1.41e-03 | 11 | 152 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Turner Syndrome, Male | 1.41e-03 | 11 | 152 | 2 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 1.41e-03 | 11 | 152 | 2 | C1527404 | |
| Disease | glioblastoma (is_marker_for) | 1.52e-03 | 44 | 152 | 3 | DOID:3068 (is_marker_for) | |
| Disease | basal cell carcinoma (is_implicated_in) | 1.68e-03 | 12 | 152 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | gallbladder carcinoma (is_marker_for) | 1.68e-03 | 12 | 152 | 2 | DOID:4948 (is_marker_for) | |
| Disease | X-12707 measurement | 1.68e-03 | 12 | 152 | 2 | EFO_0800720 | |
| Disease | alpha fetoprotein measurement | 1.81e-03 | 100 | 152 | 4 | EFO_0010583 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 1.98e-03 | 13 | 152 | 2 | C1846647 | |
| Disease | Muscular Dystrophy, Facioscapulohumeral | 1.98e-03 | 13 | 152 | 2 | C0238288 | |
| Disease | Pneumoconiosis | 2.30e-03 | 14 | 152 | 2 | C0032273 | |
| Disease | Bagassosis | 2.30e-03 | 14 | 152 | 2 | C0004681 | |
| Disease | ascorbic acid 3-sulfate measurement | 2.30e-03 | 14 | 152 | 2 | EFO_0800173 | |
| Disease | triacylglycerol 46:2 measurement | 2.30e-03 | 14 | 152 | 2 | EFO_0010402 | |
| Disease | malignant pleural mesothelioma (is_marker_for) | 2.30e-03 | 14 | 152 | 2 | DOID:7474 (is_marker_for) | |
| Disease | infant head circumference | 2.65e-03 | 15 | 152 | 2 | EFO_0004577 | |
| Disease | Chromosome Aberrations | 3.02e-03 | 16 | 152 | 2 | C0008625 | |
| Disease | Schizoaffective disorder-bipolar type | 3.02e-03 | 16 | 152 | 2 | EFO_0009965 | |
| Disease | Autosome Abnormalities | 3.02e-03 | 16 | 152 | 2 | C0004403 | |
| Disease | fourth ventricle volume measurement | 3.02e-03 | 16 | 152 | 2 | EFO_0010303 | |
| Disease | thyroxine measurement, triiodothyronine measurement | 3.41e-03 | 17 | 152 | 2 | EFO_0005130, EFO_0008392 | |
| Disease | migraine disorder, type 2 diabetes mellitus | 3.70e-03 | 60 | 152 | 3 | MONDO_0005148, MONDO_0005277 | |
| Disease | sphingosine 1-phosphate measurement | 3.82e-03 | 18 | 152 | 2 | EFO_0800185 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 3.82e-03 | 18 | 152 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | essential hypertension (is_implicated_in) | 3.82e-03 | 18 | 152 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | serum dimethylarginine measurement | 4.25e-03 | 63 | 152 | 3 | EFO_0005418 | |
| Disease | cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant | 4.26e-03 | 19 | 152 | 2 | EFO_0007044, EFO_0020106 | |
| Disease | Malignant Neoplasms | 4.41e-03 | 128 | 152 | 4 | C0006826 | |
| Disease | Drug-Induced Liver Disease | 5.08e-03 | 404 | 152 | 7 | C0860207 | |
| Disease | Drug-Induced Acute Liver Injury | 5.08e-03 | 404 | 152 | 7 | C3658290 | |
| Disease | Hepatitis, Toxic | 5.08e-03 | 404 | 152 | 7 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 5.08e-03 | 404 | 152 | 7 | C4279912 | |
| Disease | Chemical and Drug Induced Liver Injury | 5.08e-03 | 404 | 152 | 7 | C4277682 | |
| Disease | Hepatitis, Drug-Induced | 5.08e-03 | 404 | 152 | 7 | C1262760 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QALMPTLEALYRQDP | 1056 | Q09472 | |
| NMVIPVPEAESNIAY | 71 | Q9H2F5 | |
| YIPEVQFANVLTMEP | 91 | P55198 | |
| LTMEPIVLQYVPHDR | 101 | P55198 | |
| LSPRMQNNEELPTYE | 96 | Q4VCS5 | |
| NYITMDELRRELPPD | 841 | P12814 | |
| EEEQTVLTPMPAYAR | 966 | Q9NZJ5 | |
| NDPEYIRERNMSPDL | 31 | Q9UEY8 | |
| ADLMQNYDPNLRPAE | 31 | P07510 | |
| PLNTPENREYLAEIM | 116 | Q9P1U1 | |
| PYVEEMILSDATQPL | 421 | Q9UDR5 | |
| TELYTRMPVLPEDQD | 1346 | Q99758 | |
| YINDPNMTRPVDDIP | 416 | P51793 | |
| ELQTIFDTLPPMRYQ | 931 | P11532 | |
| MLPIYPAIDIDAQTE | 1066 | O75179 | |
| MPYEDIRNVILEVNE | 726 | O60879 | |
| IMPNPELAEQFVERN | 31 | Q9GZS0 | |
| FEELGRAEVPVQMPY | 556 | Q9BYV7 | |
| RYMPPEVLDESLNRN | 376 | O00238 | |
| QPLMYSVQEALNARP | 781 | Q9UPW5 | |
| EVRIDPNNPEYSDLM | 676 | Q6DHV5 | |
| PYETMQPLQVALEDI | 2701 | Q9H251 | |
| IQQMPRAIEDPILAY | 296 | P61962 | |
| DETIQNPPMETLYII | 571 | Q9P241 | |
| IDENYCDPEVRPLME | 1241 | P59510 | |
| PRPEDCPQDIYNVMV | 351 | Q07912 | |
| PVRLEAMYEVIDQGP | 251 | Q76M96 | |
| PPMAIFELLDYIVNE | 306 | Q02750 | |
| MAIFELLDYIVNEPP | 316 | P36507 | |
| PLPVEQRMDIRNYIL | 76 | Q9H2T7 | |
| YLKEPVPMQDQEQVL | 436 | P20936 | |
| RERPPLYQADEAAAM | 1401 | Q9H0J4 | |
| QPVYPLDIVRTMRDQ | 876 | P29074 | |
| RLPPELAQFYLAEMV | 166 | Q6DT37 | |
| VVLDDNDNRPMILYP | 551 | Q9Y5F3 | |
| PEYNRPLLANDLMLI | 106 | Q9Y5K2 | |
| NPFLMDDIERYPQVR | 266 | Q6ZNQ3 | |
| YPQVPDEKDLMTQLR | 531 | O75427 | |
| NLLLDMYPETVQPEE | 391 | P0C881 | |
| NLLLDMYPETVQPEE | 391 | B2RC85 | |
| IMPSQLRPVTYQDFE | 716 | Q5HY92 | |
| LVSVNEAPYRNMLPA | 351 | Q96LI6 | |
| DEYMIPIENLVNPRA | 546 | Q9NZR2 | |
| LSPEQEGQLMPRYEE | 306 | Q8N201 | |
| LEMTYVPNIDRISPE | 651 | Q9ULD2 | |
| PQREALPMDTEVYES | 336 | P43405 | |
| YLNEPVRSRQPVNME | 426 | Q8NCI6 | |
| PPMYLQADIEAFDIR | 166 | Q9HCE5 | |
| REYPRMQVTVFDLPD | 471 | O95671 | |
| PVPMYSDEDLAQVVD | 1071 | O60318 | |
| MEDPYQRPELQFFPL | 861 | A9Z1Z3 | |
| EDLMQVYDQFTLAPP | 1381 | O15550 | |
| PNTFQIDVMYEEEPL | 186 | P35226 | |
| GDQPPDIEYQIREMI | 146 | Q9UQ16 | |
| INAIEQDYRLPPPMD | 836 | P29323 | |
| SNYEVIRNQPLMIAP | 3976 | Q9Y6V0 | |
| YMIERPEPEFQDLNE | 91 | Q9BUL8 | |
| PLLNPIIYTLRNEEM | 281 | Q8NGD5 | |
| PRLDPEEIQMADYIS | 461 | O14511 | |
| MKPQEQLTLEPYERD | 291 | P22087 | |
| LRPLQEDKMQYLQVP | 376 | Q6NV75 | |
| DRVALVYPNNDPVMF | 401 | Q9P265 | |
| NFVTEEMINPYRNLP | 261 | Q01650 | |
| AYAIIQELMLPRDPI | 531 | Q8N4P6 | |
| KYDEPNRQPFMVDIL | 216 | Q8IXQ5 | |
| MNVIDRKPYPDDENL | 216 | A6NEC2 | |
| ENIMLVDPVRQPYRV | 326 | Q9H422 | |
| NEEEELSPPLMEYNI | 606 | Q86Y13 | |
| VAYIPDEMAAQQNPL | 151 | O00425 | |
| IDLRVYVPPNIMGEE | 2096 | Q96RW7 | |
| NEEEPMEGVPLEQYR | 106 | Q9C086 | |
| YINDPMAPEIVNIVE | 496 | Q9UMZ3 | |
| RNYFDPLMDEEINPR | 91 | Q8IZS5 | |
| ELMELVPQPLVDSYR | 376 | O15350 | |
| MDAAQYPLPEEVDVL | 36 | P23771 | |
| PLNTPENREYTAEIM | 116 | P61158 | |
| RDIISPELMADYLQP | 1111 | Q13535 | |
| AIYELAISQPRLDMP | 661 | Q9BZJ0 | |
| RFDDLMANIPLPEYT | 1061 | Q9Y4C1 | |
| PEIIMPGDVRNDIYV | 416 | Q14185 | |
| IPDYVDVLQMDRVPD | 1426 | Q8IZD9 | |
| PFIDMINSVPLRQIY | 136 | Q9HCG7 | |
| VALAVYLPMPEDDNN | 66 | Q13698 | |
| PYPGMNNREVLEQVE | 466 | P06241 | |
| PFPVELLQDIMNYIV | 426 | P17213 | |
| EYKIPRNEADGMPIN | 131 | P26441 | |
| YPEMDARQERVEVLP | 331 | Q00587 | |
| PAAMYRLLTAQEQPV | 821 | Q02410 | |
| PVPMVALYNAENVEV | 96 | Q6ZWL3 | |
| LAEVIPDPYVMSLQN | 216 | O43303 | |
| LPPDMYECLRVANEV | 321 | P51884 | |
| QYLIEPEKIQEMFPL | 161 | Q9UI17 | |
| RMPRVENCPDELYDI | 461 | P07948 | |
| EMALPFINYEPETLQ | 371 | P10911 | |
| PVPQEPSMEYQDAVR | 36 | Q05932 | |
| AQPRLMEPIYLVEIQ | 736 | P13639 | |
| DINFRRLEANMLEPP | 451 | P32298 | |
| RVNDVPEEFMYNPLT | 631 | O95487 | |
| PLIRYILEMSENNAP | 621 | Q58EX2 | |
| MNVIDRKPYPDDENL | 216 | P55786 | |
| VPQPEYRQLLVEAIM | 1131 | P46019 | |
| RGYLEVIPNPKDNEM | 121 | Q5TDP6 | |
| PLNVFEMLVIPEQEY | 671 | Q9Y4K4 | |
| PPEIVIYQELRMEAF | 256 | Q14914 | |
| EEMERLPVDLQYLPP | 261 | Q9BTY7 | |
| LYKVVLEAMARDPPN | 491 | Q6ZW31 | |
| KDREMPPVDPNILDY | 281 | P78332 | |
| IRTLVDNDQEPPYSM | 111 | Q96DX4 | |
| AMEPQALYDEVRTVP | 651 | A6NHR9 | |
| DPAEALQLPMDYVQR | 281 | Q9Y285 | |
| PVVELLSNPDYINQM | 141 | Q9H3E2 | |
| QIELRTYVMPNAPVD | 241 | Q14249 | |
| ILPQYIFNSRDPIVM | 1096 | O60841 | |
| YGPPQKIIMDQRDEF | 196 | Q9NXP7 | |
| LPSVNTMEEEYPRIE | 1571 | Q96Q15 | |
| EDLVYSQPEMRERHP | 481 | Q15678 | |
| LLEPMTNDPVNYVRQ | 671 | Q99460 | |
| PSPEMIRALEYIENL | 51 | P13521 | |
| PMVYRALEAPSIQIQ | 451 | Q6P3W7 | |
| MQAVINETPLPIDLY | 2051 | Q9UKZ4 | |
| IYPSPEELEAVQNMV | 21 | Q96SI9 | |
| VPPNVNNAVYMILED | 971 | Q9BZV3 | |
| MELIQDTSRPPLEYV | 1 | P0DMN0 | |
| MELIQDTSRPPLEYV | 1 | P0DMM9 | |
| PQRIRELVPESQAYM | 146 | Q92925 | |
| SELEEMEYEQQPAPV | 791 | Q9Y566 | |
| PLPMADRLYTELTEN | 1526 | Q8NFU7 | |
| VPLYTDPQEVLEMRN | 486 | P35612 | |
| NNPEYLRERNMAPDL | 31 | P35611 | |
| PDSQLVQPLVYMERL | 71 | O43529 | |
| MAPAPEQIVTLYDDE | 1591 | Q9BXT8 | |
| FYVAVPEIMPELNRL | 196 | Q9BYD6 | |
| ELREDDFQPLMQLPN | 381 | Q9NR97 | |
| EHMPPESVDQYRKQI | 756 | P55060 | |
| NYEAAQEALTDMPPR | 266 | Q8N4P2 | |
| RQDLNAPDLYIPTMA | 131 | O95070 | |
| YPLPLDLEQQAVEFM | 61 | Q13905 | |
| VQEGDPRYMAPELLQ | 266 | Q99640 | |
| FTVLPALMNEYRVPE | 1126 | O75533 | |
| MELIQDTSRPPLEYV | 1 | P50225 | |
| MELIQDISRPPLEYV | 1 | P50226 | |
| LFAEQPRQDLDPVMD | 506 | Q96RF0 | |
| PMELYQPSAESLRQQ | 221 | Q96BH1 | |
| EIPEYENLPFIMAIR | 756 | Q6ZV73 | |
| IIIIEFNPMYPKDND | 276 | Q9NRS4 | |
| PRYLEIRAVMEQIPE | 1106 | Q9HAV4 | |
| ENYIPKEPLTLQARM | 111 | Q6H3X3 | |
| EDYLNPPVIDRMDVQ | 1281 | Q709C8 | |
| EEKPPYAMLRNNLEA | 441 | Q8IV63 | |
| VMEESLYLQLDPAIP | 496 | Q9HBG4 | |
| NYEVAQETLTDMPPR | 266 | Q86WT1 | |
| PNALFVVYEQMRPQD | 211 | O60294 | |
| RMYVFRNLDPEEPIQ | 616 | Q9P2L0 | |
| MDRVYEIPEEPNVDP | 1 | Q6PP77 | |
| LDLSVQYPPENLRVM | 336 | Q96LC7 | |
| LMREEPQPQEIIYEE | 2776 | Q6ZQQ6 | |
| ASDDESIPIMYRNLP | 776 | Q8IYH5 | |
| QRVDYIMQLPVPMDA | 481 | P45974 | |
| ELSRYPDEQLTPENM | 156 | Q14966 | |
| LENNLGEPIEEFMRP | 2251 | Q5THJ4 | |
| PVEYEDNRPLLDMFL | 771 | Q8WXR4 |